<?xml version="1.0"?>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName journalpublishing3.dtd?>
  <?SourceDTD.Version 3.0?>
  <?ConverterInfo.XSLTName jp2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmcid">4008614</article-id>
      <article-id pub-id-type="publisher-id">PONE-D-14-03023</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0096404</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology and life sciences</subject>
          <subj-group>
            <subject>Cell Biology</subject>
            <subj-group>
              <subject>Cell Processes</subject>
              <subj-group>
                <subject>Cell Death</subject>
                <subject>Cell Growth</subject>
                <subject>Cellular Stress Responses</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Chromosome Biology</subject>
              <subj-group>
                <subject>Chromatin</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Signal Transduction</subject>
              <subj-group>
                <subject>Cell Signaling</subject>
                <subj-group>
                  <subject>Membrane Receptor Signaling</subject>
                  <subj-group>
                    <subject>Hormone Receptor Signaling</subject>
                  </subj-group>
                </subj-group>
                <subj-group>
                  <subject>Nuclear Receptor Signaling</subject>
                </subj-group>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Cytometry</subject>
              <subject>Molecular Cell Biology</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Computational Biology</subject>
            <subj-group>
              <subject>Genome Analysis</subject>
              <subj-group>
                <subject>Gene Ontologies</subject>
                <subject>Genetic Networks</subject>
                <subject>Transcriptome Analysis</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Genetics</subject>
            <subj-group>
              <subject>Epigenetics</subject>
              <subj-group>
                <subject>Histone Modification</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Gene expression</subject>
              <subj-group>
                <subject>DNA transcription</subject>
                <subject>Gene regulation</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Genomics</subject>
              <subject>Molecular Genetics</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Immunology</subject>
            <subj-group>
              <subject>Immune Response</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Toxicology</subject>
            <subj-group>
              <subject>Genetic Toxicology</subject>
              <subject>Immunotoxicology</subject>
              <subject>Toxic Agents</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Research and Analysis Methods</subject>
          <subj-group>
            <subject>Spectrum Analysis Techniques</subject>
            <subj-group>
              <subject>Spectrophotometry</subject>
              <subj-group>
                <subject>Cytophotometry</subject>
                <subj-group>
                  <subject>Flow Cytometry</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Gene Expression Profile and Toxic Effects in Human Bronchial Epithelial Cells Exposed to Zearalenone</article-title>
        <alt-title alt-title-type="running-head">Zearalenone Exposure on Gene Expression Profile</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>So</surname>
            <given-names>Mei Yu</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tian</surname>
            <given-names>ZhiPeng</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Phoon</surname>
            <given-names>Yong Shian</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sha</surname>
            <given-names>Sha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Antoniou</surname>
            <given-names>Michael N.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>JiangWen</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>Rudolf S. S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tan-Un</surname>
            <given-names>Kian C</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <addr-line>School of Biological Sciences, The University of Hong Kong, Hong Kong SAR, China</addr-line>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <addr-line>School of Professional and Continuing Education, The University of Hong Kong, Hong Kong SAR, China</addr-line>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <addr-line>Department of Medical and Molecular Genetics, Gene Expression and Therapy Group, King's College London School of Medicine, Guy's Hospital, London, United Kingdom</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Minna</surname>
            <given-names>John D.</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
        <addr-line>Univesity of Texas Southwestern Medical Center at Dallas, United States of America</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email>address: kctanun@hku.hk</email></corresp>
        <fn fn-type="conflict">
          <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
        </fn>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: KCT. Performed the experiments: MYS YSP SS MNA. Analyzed the data: MYS YSP ZPT JWZ RW KCT. Contributed reagents/materials/analysis tools: MNA RW KCT. Wrote the paper: MYS KCT. Supervised: RW KCT.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>2</day>
        <month>5</month>
        <year>2014</year>
      </pub-date>
      <volume>9</volume>
      <issue>5</issue>
      <elocation-id>e96404</elocation-id>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>1</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>4</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-year>2014</copyright-year>
        <copyright-holder>So et al</copyright-holder>
        <license>
          <license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Zearalenone (ZEA), a mycoestrogen produced by <italic>Fusarium</italic> fungal species, is mainly found in cereal crops such as maize, wheat and barley. Although ZEA has been reported to be present in air, little is known about the health risk or the molecular basis of action when lung cells are exposed to ZEA. As ZEA has a similar structure to estrogen, its potential risk as an endocrine disrupting chemical (EDC) has thus aroused both environmental and public health concerns. The purpose of this study is to identify the responses and underlying molecular changes that occur when human bronchial epithelial BEAS-2B cells are exposed to ZEA. Differential gene expression profiles were identified in cells that were treated with 40 &#xB5;M ZEA for 6 h and 24 h by high-throughput microarray analysis using Affymetrix Human Gene 2.0 GeneChip. The array results showed that after ZEA treatment, 262 genes at 6 h and 1073 genes at 24 h were invovled in the differential regulation. Pathway analysis revealed that diverse cellular processes were affected when lung cells were exposed to ZEA resulting in impaired response to DNA damage, cell cycle arrest, down-regulation of inflammatory responses and alterations of epigenetic marks. Results of further experiments indicated that 40 &#xB5;M ZEA decreased cell viability, induced apoptosis and promoted reactive oxygen species (ROS) generation in a time-dependent manner. Immuno-suppressive effects of ZEA were further revealed through the suppression of lipopolysaccharide (LPS)-induced expression of pro-inflammatory cytokines (IL-6, IL-8 and IL-1&#x3B2;). Interestingly, the level of global DNA methylation was markedly decreased after 24 h exposure to ZEA. Collectively, these observations suggested that a broad range of toxic effects are elicited by ZEA. Particularly, ROS may play a pivotal role in ZEA-induced cell death. These adverse effects observed in lung cells suggest that exposure to ZEA may increase susceptibility of lung cells to diseases and required further investigations.</p>
      </abstract>
      <funding-group>
        <funding-statement>The work was supported by the Seed Funding Programme for Basic Research and CRCG grants for postgraduate students of the University of Hong Kong as well as funding from HKU School of Professional and Continuing Education (SPACE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
      <counts>
        <page-count count="19"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Mycotoxin Zearalenone (ZEA) is a secondary metabolite produced by various <italic>Fusarium</italic> fungal species <xref rid="pone.0096404-Caldwell1" ref-type="bibr">[1]</xref>, <xref rid="pone.0096404-Sweeney1" ref-type="bibr">[2]</xref> which are usually found in contaminated maize, wheat and barley <xref rid="pone.0096404-Zinedine1" ref-type="bibr">[3]</xref>. Due to its structural similarity to estrogen, ZEA competes with estradiol for binding to estrogen receptors (ERs) and provokes estrogenic activities. Extensive studies have found that ZEA caused endocrine disruption and reproductive disorders in <italic>in vitro</italic> models and in laboratory and farm animals <xref rid="pone.0096404-Chang1" ref-type="bibr">[4]</xref>, <xref rid="pone.0096404-Minervini1" ref-type="bibr">[5]</xref>, <xref rid="pone.0096404-Ruzsas1" ref-type="bibr">[6]</xref>, <xref rid="pone.0096404-Sheehan1" ref-type="bibr">[7]</xref>. In addition, other effects of ZEA including developmental toxicity, immunotoxicity and genotoxicity have also been reported <xref rid="pone.0096404-Zinedine1" ref-type="bibr">[3]</xref>. Increasing evidence suggested that these effects are not exclusively due to the estrogenic potency of ZEA but that oxidative stress may be an important mediator of these observed toxic effects <xref rid="pone.0096404-AbidEssefi1" ref-type="bibr">[8]</xref>, <xref rid="pone.0096404-Hassen1" ref-type="bibr">[9]</xref>, <xref rid="pone.0096404-SalahAbbes1" ref-type="bibr">[10]</xref>.</p>
      <p>Besides foods and feeds, inhalation is another route of exposure to ZEA. The detection of ZEA-producing fungi and toxigenic spores in nasal cavity has been reported <xref rid="pone.0096404-Dornbusch1" ref-type="bibr">[11]</xref>, <xref rid="pone.0096404-Yan1" ref-type="bibr">[12]</xref>. In addition, the detection of air-borne ZEA was also documented. In a Belgium study, the maximum level of ZEA detected was 2.4 &#xB5;g/kg ZEA which meant that exposure through dust inhalation for workers in those companies was estimated to be 0.1% of the tolerable daily intake of ZEA <xref rid="pone.0096404-Tangni1" ref-type="bibr">[13]</xref>. In a study carried out in Dalian, China, it was reported that the daily inhaled ZEA by a worker in a poultry house was estimated to be 17.432&#x2013;20.512 ng respectively <xref rid="pone.0096404-Wang1" ref-type="bibr">[14]</xref>.</p>
      <p>Estrogens have been shown to induce proliferation of non-small cell lung cancer (NSCLC) through ER-mediated signaling pathways <xref rid="pone.0096404-MrquezGarbn1" ref-type="bibr">[15]</xref>. Additionally, estrogen is also involved in the activation of carcinogens via the metabolism of polycyclic aromatic hydrocarbonds (PAHs) which promotes the formation of catechol estrogens and potentially mutagenic DNA adducts <xref rid="pone.0096404-Siegfried1" ref-type="bibr">[16]</xref>, <xref rid="pone.0096404-Cavalieri1" ref-type="bibr">[17]</xref>. Interestingly, large cohort epidemiological studies indicate that females are more susceptible to developing chronic lung diseases including asthma and Chronic Obstructive Pulmonary Disease (COPD) <xref rid="pone.0096404-Tam1" ref-type="bibr">[18]</xref>.</p>
      <p>To date, the molecular basis of the effects of ZEA in lung cells has not been fully investigated. Using a toxigenomic approach, we attempted to study the mechanism of actions of ZEA on lung cells. In addition, we show that ZEA induces a broad range of toxic effect not solely because of its estrogenic potency but also through induction of oxidative stress. A BEAS-2B cell line over-expressing a free radical scavenger, cytoglobin (CYGB) confirm that ZEA generates free radicals.</p>
    </sec>
    <sec sec-type="materials|methods" id="s2">
      <title>Materials and Methods</title>
      <sec id="s2a">
        <title>Cell culture and treatments</title>
        <p>Human bronchial epithelial BEAS-2B cell line <xref rid="pone.0096404-Reddel1" ref-type="bibr">[19]</xref> (from the American Type Culture Collection, ATCC) was cultured in Dulbecco's Modified Eagles Medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS) and 100 U/ml of penicillin and 10 &#xB5;g/ml of streptomycin. All cells were maintained in a 37&#xB0;C humidified incubator with 5% CO<sub>2</sub>. DMEM with Geneticin (G418, 200 &#xB5;g/ml) were used to maintain and select Cygb overexpressing cells.</p>
        <p>ZEA powder (Sigma) was dissolved in DMSO, aliquoted and stored at &#x2212;20&#xB0;C. The stock solution of ZEA was freshly diluted by culture medium before use. BEAS-2B cells were seeded overnight to achieve confluency. Cells were exposed to different concentration of ZEA or 0.05% DMSO solvent control for different durations (6, 12, 24 and 48 h) depend on experiments. For immune-responsive experiments, cells were stimulated by 2 &#xB5;g/ml lipopolysaccharide (LPS, Sigma) for 6 h.</p>
      </sec>
      <sec id="s2b">
        <title>Cell viability assay</title>
        <p>1&#xD7;10<sup>4</sup>&#x2013;1&#xD7;10<sup>5</sup> cells were seeded in 96-well plates. After incubation overnight, cells were exposed to a serial concentration of ZEA (from 0 to 160 uM) for 6 h, 24 h or 48 h. 20 &#xB5;l of 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide (MTT, Invitrogen) solution was then added to each well. After 3 hours incubation, the medium was removed and DMSO was added to dissolve the purple formazan. The optical density of each well was quantified by measuring absorbance at 540 nm. The viabilities of treated groups were expressed as a percentage of control group, which was assumed as 100%.</p>
      </sec>
      <sec id="s2c">
        <title>Sample preparation and RNA extraction</title>
        <p>5&#xD7;10<sup>5</sup> cells were seeded onto 6-well plates. After incubation overnight, cells were treated with either 0.05% DMSO (solvent control) or 40 &#xB5;M ZEA (treatment) for 6 h and 24 h. RNA was extracted by Trizol reagent (Invitrogen) according to the manufacturer's protocol. The quality of RNA for microarray analysis was analyzed by the RNA 6000 Nano total RNA Assay using the Agilent 2100 Bioanalyzer. Only RNA samples with an A<sub>260</sub>/A<sub>280</sub> ratio &#x223C;1.8, 28S/18S ratio larger than 1.8 and RNA integrity number (RIN) larger than 8.0 were used for downstream GeneChip analysis.</p>
      </sec>
      <sec id="s2d">
        <title>Gene expression profiling and data analysis</title>
        <p>The gene expression profiles were determined using GeneChip&#xAE; Human Gene 2.0 ST Arrays (Affymetrix). Samples were hybridized onto array chips, stained, washed, and scanned according to Affymetrix protocol. The array image and cell intensity files (.CEL files) were generated by Affymetric GeneChip Command Console. Both the RNA quality control tests and GeneChip analysis were conducted by Center for Genomic Services, HKU.</p>
        <p>The data of GeneChip were analyzed using Agilent GeneSpring GX11 Software, Affrymetrix Transcriptome Analysis Console (TAC) Software and R software (<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org">http://www.r-project.org</ext-link>). When using the GeneSpring Software, filtering was performed to remove background noise. Probes that have signals weaker than 20<sup>th</sup> percentile of overall signal were not included into analysis. Differentially expressed genes were identified as fold change &#x2265;1.5 and p&lt;0.05 by unpaired t-test. Over-represented Gene Ontology (GO) terms and enriched pathways associated with the list of differentially expressed genes were generated by the built-in GO and Single Experiment Analysis (SEA) of GeneSpring. Only GO terms and pathways that have more than 2 entities (&#x2267;3) involved and p-value &lt;0.05 were considered.</p>
        <p>To further analyze the gene expression data, the Gene Set Enrichment Analysis (GSEA) were used to identify cohorts of genes which are linked to certain biological processes/cellular signaling pathways. Differentially expressed genes with annotations and known features were subjected to GSEA. Pathways are ranked according to the significance of enrichment <xref rid="pone.0096404-Subramanian1" ref-type="bibr">[61]</xref>. Gene sets with a p-value &lt;0.05 by one-way ANOVA and False Discovery Rate (FDR) &lt;0.05 by multiple test correction of were considered to be significantly affected.</p>
      </sec>
      <sec id="s2e">
        <title>Validation of gene expression by Quantitative Real-time PCR (qPCR)</title>
        <p>cDNA was synthesized from 1 &#xB5;g RNA by using PrimeScript&#x2122; RT Master Mix (Takara) according to manufacturer's instructions. Primers were designed to avoid amplification of genomic DNA using Primer Premier 5 software. The sequences of the primers used are shown in <xref ref-type="supplementary-material" rid="pone.0096404.s001">Table S1</xref>. qPCR was performed using FastStart Universal SYBR Green Master mix (Roche) and reaction mixes were set up as per manufacturer's instructions. The cycles were set as 95&#xB0;C, 10 min, 40 cycles of 95&#xB0;Cfor 15 sec, 60&#xB0;Cfor 20 sec and 72&#xB0;Cfor 45 sec followed by melting curve analysis. The change in gene expression was calculated by comparative C<sub>T</sub> method with the housekeeping gene &#x3B2;&#x2013;actin used for normalization.</p>
      </sec>
      <sec id="s2f">
        <title>Measurement of Reactive Oxygen Species (ROS) levels by DCFH-DA assay</title>
        <p>The intracellular ROS levels were quantified by a fluorescent probe, 2&#x2032;,7&#x2032;-dichlorofluorescein-diacetate (DCFH-DA, Molecular Probes). After treatment with 40 &#xB5;M ZEA, cells were washed and resuspended in PBS at a concentration of 10<sup>6</sup> cells/ml and then incubated with 10 &#xB5;M DCFH-DA at 37&#xB0;C for 40 minutes in the dark. The ROS production was quantified by DCF fluorescence intensity from 10<sup>4</sup> cells by flow cytometry. Results were expressed as the percentage of ROS generation as compared to control.</p>
      </sec>
      <sec id="s2g">
        <title>Establishment of <italic>Cygb</italic> stably overexpressing cells</title>
        <p>The stable BEAS-2B over-expressing Cytoglobin (<italic>Cygb</italic>) by comprising the coding region of mouse <italic>Cygb</italic> which was cloned to pcDNA 3.1/V5-His A vector (Invitrogen) between Hind III and Xho I sites.</p>
        <p>To establish stably <italic>Cygb</italic> expressing cells, a 1576 bp core ubiquitously-acting chromatin opening element (UCOE, a gift from Dr. Michael Antoniou, School of Medicine, King's College London, UK) was inserted to the upstream of the CMV promoter of pcDNA 3.1/V5-His A/Cygb. Successfully transfected cells were selected using selective medium (DMEM with 10% FBS and 600 &#xB5;g/ml G418). After 14 days of selection, single colonies were picked and expression levels were checked to identify the clones with <italic>Cygb</italic> over-expression. The incorporation of the UCOE onto the <italic>Cygb</italic>&#x2013;transgene construct resulted in the sustained high expression of cytogobin in the stable BEAS-2B cell line. This stable over-expression cell line was employed as a model system to investigate the effects of free radicals generated by ZEA on cell viability.</p>
      </sec>
      <sec id="s2h">
        <title>Cell death pathway analysis by Annexin V/PI double staining</title>
        <p>The apoptotic statuses of cells were determined using Annexin V-FITC Apoptosis Detection Kit I (BD Pharmingen) following manufacturer's instructions. Briefly, cells treated with 40 &#xB5;M ZEA were washed with phosphate buffered saline (PBS) and then resuspended in binding buffer at a concentration of 10<sup>6</sup> cells/ml. Annexin V-FITC and Propidium Iodide (PI) were added to the resuspended cells. Cells were incubated for 15 min at room temperature in the dark. Apoptotic cells were analysed from 10<sup>4</sup> cells with a Beckman-Coulter FACScan flow cytometer. The percentage of living, early apoptotic and dead cells were quantified using the Modfit LT program.</p>
      </sec>
      <sec id="s2i">
        <title>Global DNA methylation analysis</title>
        <p>To obtain an insight into the epigenetic effects of ZEA, global DNA methylation levels were investigated. 5-aza-cytidine, a known DNA methylation inhibitor acting as a substitute substrate for DNA methyltransferase, was used as positive control. BEAS-2B cells were treated with DMSO, 40 &#xB5;M ZEA or 1 &#xB5;M 5-aza-cytidine for 24 h. After treatment, genomic DNA was extracted using UltraClean Tissue &amp; Cells DNA Isolation Kit (MO Bio Laboratories, Inc.) according to the manufacturer's protocols. The concentrations and qualities of DNA were quantified by NanoDrop ND-1000 Spectrophotometer (Nano-Drop Technologies) and checked by 0.7% agarose gel electrophoresis, respectively. The global DNA methylation levels were determined using MethylFlash Methylated DNA Quantification Kit (Colorimetric) (Epigentek Group Inc.) following manufacturer's instructions. DNA is bound to specifically treated strip wells that have high DNA affinity. The 5-methylcytosine of DNA is detected using antibodies and quantified using an ELISA-like reaction by reading absorbance at 450 nm.</p>
      </sec>
      <sec id="s2j">
        <title>Statistical analysis</title>
        <p>Unless otherwise specified, all data are results of 3 independent experiments, each with 3 samples per group and represent as mean&#xB1; SD. Student t-test and one-way analysis of variance (ANOVA) followed by Duncan's post hoc test were conducted using SPSS v11.5 software. Values of <italic>p</italic>&lt;0.05 were considered as significant.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <sec id="s3a">
        <title>ZEA reduced viability of BEAS-2B cells</title>
        <p>The cytotoxic effects of ZEA on cell viability were determined using MTT assay. The results revealed that ZEA induced cell death in a time- and dose-dependent manner (<italic>p</italic>&lt;0.05). After 48 h treatments, the Lowest Observable Adverse Effect Level (LOAEL) was 40 &#xB5;M, with a percentage of viable cells of 62.96&#xB1;7.30% (<xref ref-type="fig" rid="pone-0096404-g001">Figure 1</xref>). As 40 &#xB5;M has no significant inhibitory effect on cell viability after 6 h and 24 h treatments but was the LOAEL after 48 h treatment, it was chosen as the concentration for use in subsequent experiments.</p>
        <fig id="pone-0096404-g001" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Cytotoxic effects of ZEA on BEAS-2B cells determined by MTT assay.</title>
            <p>Cells were treated with increasing concentrations of ZEA (from 0 to 160 &#xB5;M) for 48 h. Cell viability was expressed as percentages of control (values taken as 100%) and are mean &#xB1; SD of at least 3 independent experiments. * represents <italic>p</italic>&lt;0.05 significantly different from control as assessed by t-test.</p>
          </caption>
          <graphic xlink:href="pone.0096404.g001"/>
        </fig>
      </sec>
      <sec id="s3b">
        <title>Identification of differentially expressed genes</title>
        <p>The number of differentially expressed genes are observed to increase in a time-dependent manner. According to the Transcriptome Analysis Console (TAC) software, out of 53,617 gene probes on the Genechip, 262 (131 genes up-regulated and 131 genes down-regulated) and 1073 (357 genes up-regulated and 716 genes down-regulated) genes were differentially expressed at 6 h and 24 h, respectively. The complete list of the differentially expressed genes and their fold change at 6 h and 24 h are shown in <xref ref-type="supplementary-material" rid="pone.0096404.s002">Table S2</xref> and <xref ref-type="supplementary-material" rid="pone.0096404.s003">S3</xref>, respectively. The number of commonly up-regulated and down-regulated genes at both time points is 67 and 68, respectively (<xref ref-type="fig" rid="pone-0096404-g002">Figure 2</xref>).</p>
        <fig id="pone-0096404-g002" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Venn diagrams of differential expressed genes at different time points after ZEA treatment.</title>
            <p>The blue circles represent 6(A) Up-regulated genes. (B) Down-regulated genes.</p>
          </caption>
          <graphic xlink:href="pone.0096404.g002"/>
        </fig>
        <p>For both time-point, the most significantly up-regulated genes are heat shock proteins of 70 kDA in size (HSPA1B, HSPA1A) which increased by 3.7-fold and 6.54-fold at 6 h and 24 h, respectively (<xref ref-type="table" rid="pone-0096404-t001">Table 1</xref> and <xref ref-type="table" rid="pone-0096404-t002">Table 2</xref>). On the other hand, the most significantly down-regulated gene common for both time points is serpin peptidase inhibitor, clade B (ovalbumin), member 2 and 10 (SERPINB2, B10) which decreased by 2.87-fold and 5.52-fold at 6 h and 24 h, respectively.</p>
        <table-wrap id="pone-0096404-t001" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>The 30 most differentially expressed genes in BEAS-2B cells after 6 h treatment with ZEA.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0096404-t001-1" xlink:href="pone.0096404.t001"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Gene symbol</td>
                  <td align="left" rowspan="1" colspan="1">Gene description</td>
                  <td align="left" rowspan="1" colspan="1">Fold change</td>
                  <td align="left" rowspan="1" colspan="1">p-value</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>
                      <italic>Up-regulated:</italic>
                    </bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HSPA1B, HSPA1A</td>
                  <td align="left" rowspan="1" colspan="1">Heat shock 70 kDa protein 1B, heat shock 70 kDa protein 1A</td>
                  <td align="left" rowspan="1" colspan="1">3.78</td>
                  <td align="left" rowspan="1" colspan="1">7.87E-07</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SDIM1</td>
                  <td align="left" rowspan="1" colspan="1">Stress responsive DNAJB4 interacting membrane protein 1</td>
                  <td align="left" rowspan="1" colspan="1">2.63</td>
                  <td align="left" rowspan="1" colspan="1">0.00041</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">COPG2IT1</td>
                  <td align="left" rowspan="1" colspan="1">COPG2 imprinted transcript 1 (non-protein coding)</td>
                  <td align="left" rowspan="1" colspan="1">2.56</td>
                  <td align="left" rowspan="1" colspan="1">0.00087</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DNAJA4</td>
                  <td align="left" rowspan="1" colspan="1">DnaJ (Hsp40) homolog, subfamily A, member 4</td>
                  <td align="left" rowspan="1" colspan="1">2.29</td>
                  <td align="left" rowspan="1" colspan="1">8.2E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">LINC00473</td>
                  <td align="left" rowspan="1" colspan="1">Long intergenic non-protein coding RNA 473</td>
                  <td align="left" rowspan="1" colspan="1">2.29</td>
                  <td align="left" rowspan="1" colspan="1">6.4E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PARD6G-AS1</td>
                  <td align="left" rowspan="1" colspan="1">PARD6G antisense RNA 1 (non-protein coding)</td>
                  <td align="left" rowspan="1" colspan="1">2.25</td>
                  <td align="left" rowspan="1" colspan="1">7.2E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">FAM72C</td>
                  <td align="left" rowspan="1" colspan="1">Family with sequence similarity 72, member C</td>
                  <td align="left" rowspan="1" colspan="1">2.22</td>
                  <td align="left" rowspan="1" colspan="1">0.0003</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HSPA4L</td>
                  <td align="left" rowspan="1" colspan="1">Heat shock 70 kDa protein 4-like</td>
                  <td align="left" rowspan="1" colspan="1">2.17</td>
                  <td align="left" rowspan="1" colspan="1">1.7E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DDIT4</td>
                  <td align="left" rowspan="1" colspan="1">DNA-damage-inducible transcript 4</td>
                  <td align="left" rowspan="1" colspan="1">2.15</td>
                  <td align="left" rowspan="1" colspan="1">0.00044</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ARL17A, ARL17B</td>
                  <td align="left" rowspan="1" colspan="1">ADP-ribosylation factor-like 17A, ADP-ribosylation factor-like 17B, ADP-ribosylation factor-like protein 17-like</td>
                  <td align="left" rowspan="1" colspan="1">2.13</td>
                  <td align="left" rowspan="1" colspan="1">9.25E-07</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">BAG3</td>
                  <td align="left" rowspan="1" colspan="1">BCL2-associated athanogene 3</td>
                  <td align="left" rowspan="1" colspan="1">2.12</td>
                  <td align="left" rowspan="1" colspan="1">2.1E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MT1F</td>
                  <td align="left" rowspan="1" colspan="1">Metallothionein 1F</td>
                  <td align="left" rowspan="1" colspan="1">2.05</td>
                  <td align="left" rowspan="1" colspan="1">0.00039</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DRP2</td>
                  <td align="left" rowspan="1" colspan="1">Dystrophin related protein 2</td>
                  <td align="left" rowspan="1" colspan="1">2.03</td>
                  <td align="left" rowspan="1" colspan="1">0.00581</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CHORDC1</td>
                  <td align="left" rowspan="1" colspan="1">Cysteine and histidine-rich domain (CHORD) containing 1</td>
                  <td align="left" rowspan="1" colspan="1">2.02</td>
                  <td align="left" rowspan="1" colspan="1">0.00012</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">LINC00310</td>
                  <td align="left" rowspan="1" colspan="1">Long intergenic non-protein coding RNA 310</td>
                  <td align="left" rowspan="1" colspan="1">1.98</td>
                  <td align="left" rowspan="1" colspan="1">6.9E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>
                      <italic>Down-regulated:</italic>
                    </bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">KRTAP2-4</td>
                  <td align="left" rowspan="1" colspan="1">Keratin associated protein 2-4-like, keratin associated protein 2-4</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.28</td>
                  <td align="left" rowspan="1" colspan="1">7.7E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SERPINB2, SERPINB10</td>
                  <td align="left" rowspan="1" colspan="1">Serpin peptidase inhibitor, clade B (ovalbumin), member 2, serpin peptidase Inhibitor, clade B (ovalbumin), member 10</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.87</td>
                  <td align="left" rowspan="1" colspan="1">4E-06</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PLAU</td>
                  <td align="left" rowspan="1" colspan="1">Plasminogen activator, urokinase</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.79</td>
                  <td align="left" rowspan="1" colspan="1">4.2E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SHISA2</td>
                  <td align="left" rowspan="1" colspan="1">Shisa homolog 2 (Xenopus laevis)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.72</td>
                  <td align="left" rowspan="1" colspan="1">0.00001</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CYP1B1</td>
                  <td align="left" rowspan="1" colspan="1">Cytochrome P450, family 1, subfamily B, polypeptide 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.66</td>
                  <td align="left" rowspan="1" colspan="1">7E-06</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DLX2</td>
                  <td align="left" rowspan="1" colspan="1">Distal-less homeobox 2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.63</td>
                  <td align="left" rowspan="1" colspan="1">0.00007</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">EDN1</td>
                  <td align="left" rowspan="1" colspan="1">Endothelin 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.57</td>
                  <td align="left" rowspan="1" colspan="1">6.9E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">FOSL1</td>
                  <td align="left" rowspan="1" colspan="1">FOS-like antigen 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.44</td>
                  <td align="left" rowspan="1" colspan="1">1.1E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ADAMTS1</td>
                  <td align="left" rowspan="1" colspan="1">ADAM metallopeptidase with thrombospondin type 1 motif, 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.29</td>
                  <td align="left" rowspan="1" colspan="1">0.00062</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SMAD7</td>
                  <td align="left" rowspan="1" colspan="1">SMAD family member 7</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.24</td>
                  <td align="left" rowspan="1" colspan="1">0.00039</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">KLF10</td>
                  <td align="left" rowspan="1" colspan="1">Kruppel-like factor 10</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.22</td>
                  <td align="left" rowspan="1" colspan="1">0.00018</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IL8</td>
                  <td align="left" rowspan="1" colspan="1">Interleukin 8</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.22</td>
                  <td align="left" rowspan="1" colspan="1">0.0107</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">KRT80</td>
                  <td align="left" rowspan="1" colspan="1">Keratin 80</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.11</td>
                  <td align="left" rowspan="1" colspan="1">0.00016</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">RUNX2</td>
                  <td align="left" rowspan="1" colspan="1">Runt-related transcription factor 2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.05</td>
                  <td align="left" rowspan="1" colspan="1">2.6E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">LOC100131234</td>
                  <td align="left" rowspan="1" colspan="1">Familial acute myelogenous leukemia related factor</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.04</td>
                  <td align="left" rowspan="1" colspan="1">8.4E-05</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
        </table-wrap>
        <table-wrap id="pone-0096404-t002" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.t002</object-id>
          <label>Table 2</label>
          <caption>
            <title>The 30 most differentially expressed genes in BEAS-2B cells after 24 h treatment with ZEA.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0096404-t002-2" xlink:href="pone.0096404.t002"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Gene symbol</td>
                  <td align="left" rowspan="1" colspan="1">Gene name</td>
                  <td align="left" rowspan="1" colspan="1">Fold change</td>
                  <td align="left" rowspan="1" colspan="1">p-value</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>
                      <italic>Up-regulated:</italic>
                    </bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HSPA1B, HSPA1A</td>
                  <td align="left" rowspan="1" colspan="1">Heat shock 70 kDa protein 1B, heat shock 70 kDa protein 1A</td>
                  <td align="left" rowspan="1" colspan="1">6.54</td>
                  <td align="left" rowspan="1" colspan="1">3.46E-08</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">NR4A3</td>
                  <td align="left" rowspan="1" colspan="1">Nuclear receptor subfamily 4, group A, member 3</td>
                  <td align="left" rowspan="1" colspan="1">5.79</td>
                  <td align="left" rowspan="1" colspan="1">0.00018</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CLDN12, CDK14</td>
                  <td align="left" rowspan="1" colspan="1">Claudin 12, cyclin-dependent kinase 14</td>
                  <td align="left" rowspan="1" colspan="1">5.25</td>
                  <td align="left" rowspan="1" colspan="1">0.00074</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">AGBL5-AS1</td>
                  <td align="left" rowspan="1" colspan="1">AGBL5 antisense RNA 1 (non-protein coding)</td>
                  <td align="left" rowspan="1" colspan="1">4.11</td>
                  <td align="left" rowspan="1" colspan="1">0.0001</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">LMOD1</td>
                  <td align="left" rowspan="1" colspan="1">Leiomodin 1 (smooth muscle)</td>
                  <td align="left" rowspan="1" colspan="1">3.91</td>
                  <td align="left" rowspan="1" colspan="1">4.9E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DNAJA4</td>
                  <td align="left" rowspan="1" colspan="1">DnaJ (Hsp40) homolog, subfamily A, member 4</td>
                  <td align="left" rowspan="1" colspan="1">3.32</td>
                  <td align="left" rowspan="1" colspan="1">4.5E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CHORDC1</td>
                  <td align="left" rowspan="1" colspan="1">Cysteine and histidine-rich domain (CHORD) containing 1</td>
                  <td align="left" rowspan="1" colspan="1">2.96</td>
                  <td align="left" rowspan="1" colspan="1">2.9E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">LRP4-AS1</td>
                  <td align="left" rowspan="1" colspan="1">LRP4 antisense RNA 1 (non-protein coding)</td>
                  <td align="left" rowspan="1" colspan="1">2.95</td>
                  <td align="left" rowspan="1" colspan="1">0.00208</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SDIM1</td>
                  <td align="left" rowspan="1" colspan="1">Stress responsive DNAJB4 interacting membrane protein 1</td>
                  <td align="left" rowspan="1" colspan="1">2.79</td>
                  <td align="left" rowspan="1" colspan="1">0.00018</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HSPA4L</td>
                  <td align="left" rowspan="1" colspan="1">Heat shock 70 kDa protein 4-like</td>
                  <td align="left" rowspan="1" colspan="1">2.75</td>
                  <td align="left" rowspan="1" colspan="1">1.3E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HSPH1</td>
                  <td align="left" rowspan="1" colspan="1">Heat shock 105 kDa/110 kDa protein 1</td>
                  <td align="left" rowspan="1" colspan="1">2.66</td>
                  <td align="left" rowspan="1" colspan="1">6.3E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DDIT4</td>
                  <td align="left" rowspan="1" colspan="1">DNA-damage-inducible transcript 4</td>
                  <td align="left" rowspan="1" colspan="1">2.62</td>
                  <td align="left" rowspan="1" colspan="1">1.7E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ALDH1L2</td>
                  <td align="left" rowspan="1" colspan="1">Aldehyde dehydrogenase 1 family, member L2</td>
                  <td align="left" rowspan="1" colspan="1">2.55</td>
                  <td align="left" rowspan="1" colspan="1">0.00011</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SNORD14E</td>
                  <td align="left" rowspan="1" colspan="1">Small nucleolar RNA, C/D box 14E</td>
                  <td align="left" rowspan="1" colspan="1">2.54</td>
                  <td align="left" rowspan="1" colspan="1">0.00154</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CCDC146</td>
                  <td align="left" rowspan="1" colspan="1">Coiled-coil domain containing 146</td>
                  <td align="left" rowspan="1" colspan="1">2.52</td>
                  <td align="left" rowspan="1" colspan="1">0.0004</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>
                      <italic>Down-regulated:</italic>
                    </bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HLF</td>
                  <td align="left" rowspan="1" colspan="1">Hepatic leukemia factor</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;6.4</td>
                  <td align="left" rowspan="1" colspan="1">1.8E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SERPINB2, SERPINB10</td>
                  <td align="left" rowspan="1" colspan="1">Serpin peptidase inhibitor, clade B (ovalbumin), member 2, serpin Peptidase inhibitor, clade B (ovalbumin), member 10</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;5.52</td>
                  <td align="left" rowspan="1" colspan="1">0.00067</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DIO2</td>
                  <td align="left" rowspan="1" colspan="1">Deiodinase, iodothyronine, type II</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;5.45</td>
                  <td align="left" rowspan="1" colspan="1">1.2E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PALMD</td>
                  <td align="left" rowspan="1" colspan="1">Palmdelphin</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;4</td>
                  <td align="left" rowspan="1" colspan="1">0.00019</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">F2RL2</td>
                  <td align="left" rowspan="1" colspan="1">Coagulation factor II (thrombin) receptor-like 2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.92</td>
                  <td align="left" rowspan="1" colspan="1">6.9E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MIRLET7A2</td>
                  <td align="left" rowspan="1" colspan="1">MicroRNA let-7a-2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.81</td>
                  <td align="left" rowspan="1" colspan="1">0.02093</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SHISA2</td>
                  <td align="left" rowspan="1" colspan="1">Shisa homolog 2 (Xenopus laevis)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.78</td>
                  <td align="left" rowspan="1" colspan="1">8.5E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PSG5</td>
                  <td align="left" rowspan="1" colspan="1">Pregnancy specific beta-1-glycoprotein 5</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.75</td>
                  <td align="left" rowspan="1" colspan="1">0.00002</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TACSTD2</td>
                  <td align="left" rowspan="1" colspan="1">Tumor-associated calcium signal transducer 2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.65</td>
                  <td align="left" rowspan="1" colspan="1">5.4E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SNORD116-28, SNORD115-26, SNORD115-13, SNORD115-7, SNORD107</td>
                  <td align="left" rowspan="1" colspan="1">Small nucleolar RNA, C/D box 116-28, small nucleolar RNA, C/D box 115-26, small nucleolar RNA, C/D box 115-13, small nucleolar RNA, C/D box 115-7, small nucleolar RNA, C/D box 107</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.32</td>
                  <td align="left" rowspan="1" colspan="1">0.00459</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ADAMTS1</td>
                  <td align="left" rowspan="1" colspan="1">ADAM metallopeptidase with thrombospondin type 1 motif, 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.32</td>
                  <td align="left" rowspan="1" colspan="1">0.00096</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CPA4</td>
                  <td align="left" rowspan="1" colspan="1">Carboxypeptidase A4</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.23</td>
                  <td align="left" rowspan="1" colspan="1">0.00001</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MIRLET7C</td>
                  <td align="left" rowspan="1" colspan="1">microRNA let-7c</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.22</td>
                  <td align="left" rowspan="1" colspan="1">0.0225</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">FBXO32</td>
                  <td align="left" rowspan="1" colspan="1">F-box protein 32</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.06</td>
                  <td align="left" rowspan="1" colspan="1">0.00046</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">EPGN</td>
                  <td align="left" rowspan="1" colspan="1">Epithelial mitogen homolog (mouse)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.06</td>
                  <td align="left" rowspan="1" colspan="1">0.00547</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
        </table-wrap>
      </sec>
      <sec id="s3c">
        <title>Functional classification of differentially expressed genes</title>
        <p>The identification of enriched &#x201C;Biological Processes&#x201D; under GO category was performed using GeneSpring. The enriched GO terms at 6 h and 24 h are shown in <xref ref-type="supplementary-material" rid="pone.0096404.s004">Table S4</xref> and <xref ref-type="supplementary-material" rid="pone.0096404.s005">Table S5</xref> respectively. The most significantly enriched GO term at 6 h is &#x201C;protein folding&#x201D; (p&#x200A;=&#x200A;5.59E-07) while that at 24 h is &#x201C;DNA dependent DNA replication&#x201D; (p&#x200A;=&#x200A;1.35E-14).</p>
      </sec>
      <sec id="s3d">
        <title>Pathway analysis of differentially expressed genes</title>
        <p>The pathways altered after ZEA treatments were identified by single experiment analysis (SEA) using GeneSpring. The over-represented pathways at 6 h and 24 h are shown in <xref ref-type="table" rid="pone-0096404-t003">Table 3</xref>. At 6 h, only the &#x201C;transforming growth factor-beta (TGF-&#x3B2;) signaling&#x201D; pathway is altered. At 24 h, the top five most significantly altered pathways are &#x201C;DNA Replication&#x201D;, &#x201C;G1 to S cell cycle control&#x201D;, &#x201C;cell cycle&#x201D;, &#x201C;synthesis of DNA&#x201D; and &#x201C;cholesterol biosynthesis&#x201D;. These results suggest that ZEA alters DNA replication and cell cycle progression in BEAS-2B cells. The differentially expressed genes associated with the progression of cell cycle from G1 to S phase, the replication, damage and repair of DNA and the apoptotic pathway are shown in <xref ref-type="table" rid="pone-0096404-t004">Table 4</xref>, <xref ref-type="table" rid="pone-0096404-t005">Table 5</xref> and <xref ref-type="table" rid="pone-0096404-t006">Table 6</xref> respectively.</p>
        <table-wrap id="pone-0096404-t003" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.t003</object-id>
          <label>Table 3</label>
          <caption>
            <title>Key pathways predicted by Single Experiment Analysis (SEA) following treatment with ZEA in BEAS-2B cells.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0096404-t003-3" xlink:href="pone.0096404.t003"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Pathway</td>
                  <td align="left" rowspan="1" colspan="1">Number of differential entities involved</td>
                  <td align="left" rowspan="1" colspan="1">Total number of entities in the category</td>
                  <td align="left" rowspan="1" colspan="1">p-values</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>
                      <italic>Treated with ZEA for 6 hr:</italic>
                    </bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TGF-beta signaling pathway</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">55</td>
                  <td align="left" rowspan="1" colspan="1">0.00499</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>
                      <italic>Treated with ZEA for 24 hr:</italic>
                    </bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DNA Replication</td>
                  <td align="left" rowspan="1" colspan="1">14</td>
                  <td align="left" rowspan="1" colspan="1">42</td>
                  <td align="left" rowspan="1" colspan="1">0</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">G1 to S cell cycle control</td>
                  <td align="left" rowspan="1" colspan="1">17</td>
                  <td align="left" rowspan="1" colspan="1">68</td>
                  <td align="left" rowspan="1" colspan="1">1.21E-10</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Cell cycle</td>
                  <td align="left" rowspan="1" colspan="1">19</td>
                  <td align="left" rowspan="1" colspan="1">103</td>
                  <td align="left" rowspan="1" colspan="1">2.33E-10</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Synthesis of DNA</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">13</td>
                  <td align="left" rowspan="1" colspan="1">1.01E-09</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Cholesterol biosynthesis</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">17</td>
                  <td align="left" rowspan="1" colspan="1">2.26E-08</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Regulation of DNA replication</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">6.95E-08</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SREBP signaling</td>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">56</td>
                  <td align="left" rowspan="1" colspan="1">1.45E-07</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TGF Beta Signaling Pathway</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">55</td>
                  <td align="left" rowspan="1" colspan="1">1.55E-06</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">miRNA regulation of DNA Damage Response</td>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">98</td>
                  <td align="left" rowspan="1" colspan="1">2.64E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Lymphocyte TarBase</td>
                  <td align="left" rowspan="1" colspan="1">22</td>
                  <td align="left" rowspan="1" colspan="1">420</td>
                  <td align="left" rowspan="1" colspan="1">4.97E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Epithelium TarBase</td>
                  <td align="left" rowspan="1" colspan="1">17</td>
                  <td align="left" rowspan="1" colspan="1">278</td>
                  <td align="left" rowspan="1" colspan="1">5.52E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Senescence and Autophagy</td>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">106</td>
                  <td align="left" rowspan="1" colspan="1">6.23E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DNA damage response</td>
                  <td align="left" rowspan="1" colspan="1">8</td>
                  <td align="left" rowspan="1" colspan="1">68</td>
                  <td align="left" rowspan="1" colspan="1">7.07E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">E2F-MIRHG1 feedback-loop</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">8.12E-05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Mitotic M-M-G1 phases</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">15</td>
                  <td align="left" rowspan="1" colspan="1">1.93E-04</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">AhR pathway</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">28</td>
                  <td align="left" rowspan="1" colspan="1">2.28E-04</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SREBF and miR33 in cholesterol and lipid homeostasis</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">18</td>
                  <td align="left" rowspan="1" colspan="1">4.13E-04</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">APC-C-mediated degradation of cell cycle proteins</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">9.03E-04</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">L1CAM interactions</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">27</td>
                  <td align="left" rowspan="1" colspan="1">0.0011</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">BMP signaling and regulation</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">12</td>
                  <td align="left" rowspan="1" colspan="1">0.0016</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Androgen receptor signaling pathway</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">85</td>
                  <td align="left" rowspan="1" colspan="1">0.0018</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Unfolded Protein Response</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">14</td>
                  <td align="left" rowspan="1" colspan="1">0.0021</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Leukocyte TarBase</td>
                  <td align="left" rowspan="1" colspan="1">8</td>
                  <td align="left" rowspan="1" colspan="1">128</td>
                  <td align="left" rowspan="1" colspan="1">0.0043</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">p38 MAPK Signaling Pathway</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">34</td>
                  <td align="left" rowspan="1" colspan="1">0.0048</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MAPK signaling pathway</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">161</td>
                  <td align="left" rowspan="1" colspan="1">0.0056</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TSH signaling pathway</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">65</td>
                  <td align="left" rowspan="1" colspan="1">0.010</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Complement and Coagulation Cascades</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">64</td>
                  <td align="left" rowspan="1" colspan="1">0.020</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Mitotic G1-G1-S phases</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">11</td>
                  <td align="left" rowspan="1" colspan="1">0.020</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Metabolism of nucleotides</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">12</td>
                  <td align="left" rowspan="1" colspan="1">0.024</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Apoptosis</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">83</td>
                  <td align="left" rowspan="1" colspan="1">0.027</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Integrin cell surface interactions</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">16</td>
                  <td align="left" rowspan="1" colspan="1">0.032</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Interleukin-1 signaling</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">15</td>
                  <td align="left" rowspan="1" colspan="1">0.032</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Keap1-Nrf2 Pathway</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">14</td>
                  <td align="left" rowspan="1" colspan="1">0.032</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Cancer prevention</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">15</td>
                  <td align="left" rowspan="1" colspan="1">0.036</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Cell Cycle Checkpoints</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">16</td>
                  <td align="left" rowspan="1" colspan="1">0.036</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">miRNAs involved in DDR</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">69</td>
                  <td align="left" rowspan="1" colspan="1">0.043</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Interleukin-11 Signaling Pathway</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">40</td>
                  <td align="left" rowspan="1" colspan="1">0.047</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
        </table-wrap>
        <table-wrap id="pone-0096404-t004" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.t004</object-id>
          <label>Table 4</label>
          <caption>
            <title>Differentially expressed genes related to cell cycle regulation.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0096404-t004-4" xlink:href="pone.0096404.t004"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Gene symbol</td>
                  <td align="left" rowspan="1" colspan="1">Gene description</td>
                  <td colspan="2" align="left" rowspan="1">Fold change<xref ref-type="table-fn" rid="nt101">*</xref></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">6 h</td>
                  <td align="left" rowspan="1" colspan="1">24 h</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ANAPC16</td>
                  <td align="left" rowspan="1" colspan="1">Anaphase promoting complex subunit 16</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.6</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ASNS</td>
                  <td align="left" rowspan="1" colspan="1">Asparagine synthetase (glutamine-hydrolyzing)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">2.35</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ATF3</td>
                  <td align="left" rowspan="1" colspan="1">Activating transcription factor 3</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.63</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">AURKA</td>
                  <td align="left" rowspan="1" colspan="1">Aurora kinase A</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.62</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CCNB1</td>
                  <td align="left" rowspan="1" colspan="1">Cyclin B1</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.6</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CCNE1</td>
                  <td align="left" rowspan="1" colspan="1">Cyclin E1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.33</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.11</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CCNE2</td>
                  <td align="left" rowspan="1" colspan="1">Cyclin E2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.32</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.93</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CD24</td>
                  <td align="left" rowspan="1" colspan="1">CD24 molecule</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.18</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CDC20</td>
                  <td align="left" rowspan="1" colspan="1">Cell division cycle 20 homolog (S. Cerevisiae)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.25</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CDC45</td>
                  <td align="left" rowspan="1" colspan="1">Cell division cycle 45 homolog (S. Cerevisiae)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.26</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.87</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CDC6</td>
                  <td align="left" rowspan="1" colspan="1">Cell division cycle 6 homolog (S. Cerevisiae)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.69</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CDCA3</td>
                  <td align="left" rowspan="1" colspan="1">Cell division cycle associated 3</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.72</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CDCA7</td>
                  <td align="left" rowspan="1" colspan="1">Cell division cycle associated 7</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.88</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CDK14</td>
                  <td align="left" rowspan="1" colspan="1">Cyclin-dependent kinase 14</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.66</td>
                  <td align="left" rowspan="1" colspan="1">5.25</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CDKN2B</td>
                  <td align="left" rowspan="1" colspan="1">Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.52</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CKAP5</td>
                  <td align="left" rowspan="1" colspan="1">Cytoskeleton associated protein 5</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.55</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CKS2</td>
                  <td align="left" rowspan="1" colspan="1">CDC28 protein kinase regulatory subunit 2</td>
                  <td align="left" rowspan="1" colspan="1">1.19</td>
                  <td align="left" rowspan="1" colspan="1">1.57</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CTGF</td>
                  <td align="left" rowspan="1" colspan="1">Connective tissue growth factor</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.51</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DBF4B</td>
                  <td align="left" rowspan="1" colspan="1">DBF4 homolog B (S. Cerevisiae)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.51</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DLGAP5</td>
                  <td align="left" rowspan="1" colspan="1">Discs, large (Drosophila) homolog-associated protein 5</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.52</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DSN1</td>
                  <td align="left" rowspan="1" colspan="1">DSN1, MIND kinetochore complex component, homolog (S. Cerevisiae)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.65</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">E2F1</td>
                  <td align="left" rowspan="1" colspan="1">E2F transcription factor 1</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.61</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">E2F7</td>
                  <td align="left" rowspan="1" colspan="1">E2F transcription factor 7</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.12</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.84</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">EGR1</td>
                  <td align="left" rowspan="1" colspan="1">Early growth response 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.28</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.09</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">GAS1</td>
                  <td align="left" rowspan="1" colspan="1">Growth arrest-specific 1</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">GAS2L3</td>
                  <td align="left" rowspan="1" colspan="1">Growth arrest-specific 2 like 3</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.57</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HIST1H2BB</td>
                  <td align="left" rowspan="1" colspan="1">Histone cluster 1, h2bb</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.48</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.03</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HIST1H3A-J</td>
                  <td align="left" rowspan="1" colspan="1">Histone cluster 1, H3A-J</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.34</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.66</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HIST2H2AC</td>
                  <td align="left" rowspan="1" colspan="1">Histone cluster 2, h2ac</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.24</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.58</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HIST1H1B</td>
                  <td align="left" rowspan="1" colspan="1">Histone cluster 1, h1b</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.18</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.78</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">H1F0</td>
                  <td align="left" rowspan="1" colspan="1">H1 histone family, member 0</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.9</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HIST1H2AB, HIST1H2AE</td>
                  <td align="left" rowspan="1" colspan="1">Histone cluster 1, h2ab, histone cluster 1, h2ae</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.79</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HIST1H1C</td>
                  <td align="left" rowspan="1" colspan="1">Histone cluster 1, h1c</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.77</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HIST1H2BC, HIST1H2BI, HIST1H2BE-G</td>
                  <td align="left" rowspan="1" colspan="1">Histone cluster 1, h2bc, histone cluster 1, h2bi, histone cluster 1, h2be-g</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.65</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">H1FX</td>
                  <td align="left" rowspan="1" colspan="1">H1 histone family, member X</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.6</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HIST2H4B, HIST4H4, HIST1H4A-F, HIST1H4H-L,</td>
                  <td align="left" rowspan="1" colspan="1">Histone cluster 2, h4b, histone cluster 4, H4, histone cluster 2, H4A-F histone cluster 1, H4H-L</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.58</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HIST1H2AE, HIST1H2AB</td>
                  <td align="left" rowspan="1" colspan="1">Histone cluster 1, h2ae, histone cluster 1, h2ab</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.53</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HIST1H2BN</td>
                  <td align="left" rowspan="1" colspan="1">Histone cluster 1, h2bn</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">2.2</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">H2BFXP</td>
                  <td align="left" rowspan="1" colspan="1">H2B histone family, member X, pseudogene</td>
                  <td align="left" rowspan="1" colspan="1">1.6</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">INCENP</td>
                  <td align="left" rowspan="1" colspan="1">Inner centromere protein antigens 135/155 kda</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.54</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">JUN</td>
                  <td align="left" rowspan="1" colspan="1">Jun proto-oncogene</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.35</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.67</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">KLF10</td>
                  <td align="left" rowspan="1" colspan="1">Kruppel-like factor 10</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.24</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.1</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">KLF11</td>
                  <td align="left" rowspan="1" colspan="1">Kruppel-like factor 11</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.35</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.69</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">LOC100289187|ZNF655</td>
                  <td align="left" rowspan="1" colspan="1">Transmembrane protein 225-like, zinc finger protein 655</td>
                  <td align="left" rowspan="1" colspan="1">1.51</td>
                  <td align="left" rowspan="1" colspan="1">1.92</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MYB</td>
                  <td align="left" rowspan="1" colspan="1">V-myb myeloblastosis viral oncogene homolog (avian)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.68</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MYC</td>
                  <td align="left" rowspan="1" colspan="1">V-myc myelocytomatosis viral oncogene homolog (avian)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.31</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.63</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">NEK2</td>
                  <td align="left" rowspan="1" colspan="1">NIMA (never in mitosis gene a)-related kinase 2</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">2.17</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">NEK6</td>
                  <td align="left" rowspan="1" colspan="1">NIMA (never in mitosis gene a)-related kinase 6</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.24</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.57</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">NOG</td>
                  <td align="left" rowspan="1" colspan="1">Noggin</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.95</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.35</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PAK3</td>
                  <td align="left" rowspan="1" colspan="1">P21 protein (Cdc42/Rac)-activated kinase 3</td>
                  <td align="left" rowspan="1" colspan="1">1.63</td>
                  <td align="left" rowspan="1" colspan="1">1.91</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PLK2</td>
                  <td align="left" rowspan="1" colspan="1">Polo-like kinase 2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.16</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.64</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">RHOB</td>
                  <td align="left" rowspan="1" colspan="1">Ras homolog gene family, member B</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.43</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.81</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SERPINE1</td>
                  <td align="left" rowspan="1" colspan="1">Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.09</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.33</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TGFB2</td>
                  <td align="left" rowspan="1" colspan="1">Transforming growth factor, beta 2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.75</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TGFBR1</td>
                  <td align="left" rowspan="1" colspan="1">Transforming growth factor, beta receptor 1</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.51</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TGFBR3</td>
                  <td align="left" rowspan="1" colspan="1">Transforming growth factor, beta receptor III</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.57</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">THBS1</td>
                  <td align="left" rowspan="1" colspan="1">Thrombospondin 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.59</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.47</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">UBE2C</td>
                  <td align="left" rowspan="1" colspan="1">Ubiquitin-conjugating enzyme E2C</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.77</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">UBE2S</td>
                  <td align="left" rowspan="1" colspan="1">Ubiquitin-conjugating enzyme E2S</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.62</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">WISP2</td>
                  <td align="left" rowspan="1" colspan="1">WNT1 inducible signaling pathway protein 2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.26</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.24</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt101">
              <label/>
              <p>*Only the fold change with p&lt;0.05 are shown.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="pone-0096404-t005" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.t005</object-id>
          <label>Table 5</label>
          <caption>
            <title>Differentially expressed genes related to replication, damage and repair of DNA.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0096404-t005-5" xlink:href="pone.0096404.t005"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Gene symbol</td>
                  <td align="left" rowspan="1" colspan="1">Gene name</td>
                  <td colspan="2" align="left" rowspan="1">Fold change<xref ref-type="table-fn" rid="nt102">*</xref></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">6 h</td>
                  <td align="left" rowspan="1" colspan="1">24 h</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">AGTR1</td>
                  <td align="left" rowspan="1" colspan="1">Angiotensin II receptor, type 1</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.53</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">BLM</td>
                  <td align="left" rowspan="1" colspan="1">Bloom syndrome, recq helicase-like</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.66</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">BUB1</td>
                  <td align="left" rowspan="1" colspan="1">Budding uninhibited by benzimidazoles 1 homolog (yeast)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.69</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CDC45</td>
                  <td align="left" rowspan="1" colspan="1">Cell division cycle 45 homolog (S. Cerevisiae)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.26</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.87</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CDC6</td>
                  <td align="left" rowspan="1" colspan="1">Cell division cycle 6 homolog (S. Cerevisiae)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.69</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CENPF</td>
                  <td align="left" rowspan="1" colspan="1">Centromere protein F, 350/400 kda (mitosin)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.53</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CLSPN</td>
                  <td align="left" rowspan="1" colspan="1">Claspin</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.11</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.84</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DDB2</td>
                  <td align="left" rowspan="1" colspan="1">Damage-specific DNA binding protein 2, 48 kda</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.22</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.73</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">EXO1</td>
                  <td align="left" rowspan="1" colspan="1">Exonuclease 1</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.25</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">GINS2</td>
                  <td align="left" rowspan="1" colspan="1">GINS complex subunit 2 (Psf2 homolog)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.16</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.15</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">GINS3</td>
                  <td align="left" rowspan="1" colspan="1">GINS complex subunit 3 (Psf3 homolog)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.16</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.65</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HELB</td>
                  <td align="left" rowspan="1" colspan="1">Helicase (DNA) B</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.26</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.78</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HELLS</td>
                  <td align="left" rowspan="1" colspan="1">Helicase, lymphoid-specific</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.3</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.97</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">KIF18A</td>
                  <td align="left" rowspan="1" colspan="1">Kinesin family member 18A</td>
                  <td align="left" rowspan="1" colspan="1">1.1</td>
                  <td align="left" rowspan="1" colspan="1">1.59</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">KIF2C</td>
                  <td align="left" rowspan="1" colspan="1">Kinesin family member 2C</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.9</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MCM10</td>
                  <td align="left" rowspan="1" colspan="1">Minichromosome maintenance complex component 10</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.08</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.77</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MCM2</td>
                  <td align="left" rowspan="1" colspan="1">Minichromosome maintenance complex component 2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.15</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.2</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MCM3</td>
                  <td align="left" rowspan="1" colspan="1">Minichromosome maintenance complex component 3</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.15</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.53</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MCM4</td>
                  <td align="left" rowspan="1" colspan="1">Minichromosome maintenance complex component 4</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.65</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MCM5</td>
                  <td align="left" rowspan="1" colspan="1">Minichromosome maintenance complex component 5</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.14</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.29</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MCM6</td>
                  <td align="left" rowspan="1" colspan="1">Minichromosome maintenance complex component 6</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.82</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MCM7</td>
                  <td align="left" rowspan="1" colspan="1">Minichromosome maintenance complex component 7</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.16</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.82</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">NUF2</td>
                  <td align="left" rowspan="1" colspan="1">NUF2, NDC80 kinetochore complex component, homolog (S. Cerevisiae)</td>
                  <td align="left" rowspan="1" colspan="1">1.09</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.75</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ORC1|ORC1L</td>
                  <td align="left" rowspan="1" colspan="1">Origin recognition complex, subunit 1 | origin recognition complex, subunit 1-like (S. Cerevisiae)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.89</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">POLA1</td>
                  <td align="left" rowspan="1" colspan="1">Polymerase (DNA directed), alpha 1, catalytic subunit</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.25</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.56</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">POLE2</td>
                  <td align="left" rowspan="1" colspan="1">Polymerase (DNA directed), epsilon 2 (p59 subunit)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.15</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.81</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">POLN</td>
                  <td align="left" rowspan="1" colspan="1">Polymerase (DNA directed) nu</td>
                  <td align="left" rowspan="1" colspan="1">1.85</td>
                  <td align="left" rowspan="1" colspan="1">1.56</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PRIM1</td>
                  <td align="left" rowspan="1" colspan="1">Primase, DNA, polypeptide 1 (49 kda)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.23</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.8</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PTTG1</td>
                  <td align="left" rowspan="1" colspan="1">Pituitary tumor-transforming 1</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.77</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">RAD51</td>
                  <td align="left" rowspan="1" colspan="1">RAD51 homolog (S. Cerevisiae)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.08</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.54</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">RFC2</td>
                  <td align="left" rowspan="1" colspan="1">Replication factor C (activator 1) 2, 40 kda</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.17</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.57</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">RRM2</td>
                  <td align="left" rowspan="1" colspan="1">Ribonucleotide reductase M2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.13</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.58</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">RUVBL2</td>
                  <td align="left" rowspan="1" colspan="1">Ruvb-like 2 (E. Coli)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.54</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SPC24</td>
                  <td align="left" rowspan="1" colspan="1">SPC24, NDC80 kinetochore complex component, homolog (S. Cerevisiae)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.19</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.79</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">STAG1</td>
                  <td align="left" rowspan="1" colspan="1">Stromal antigen 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.21</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.54</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TIPIN</td>
                  <td align="left" rowspan="1" colspan="1">TIMELESS interacting protein</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.58</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.64</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TK2</td>
                  <td align="left" rowspan="1" colspan="1">Thymidine kinase 2, mitochondrial</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.16</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.84</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TYMS</td>
                  <td align="left" rowspan="1" colspan="1">Thymidylate synthetase</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.18</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.53</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">UNG</td>
                  <td align="left" rowspan="1" colspan="1">Uracil-DNA glycosylase</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.77</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt102">
              <label/>
              <p>*Only the fold change with p&lt;0.05 are shown.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="pone-0096404-t006" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.t006</object-id>
          <label>Table 6</label>
          <caption>
            <title>Differentially expressed genes related to apoptosis.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0096404-t006-6" xlink:href="pone.0096404.t006"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Gene symbol</td>
                  <td align="left" rowspan="1" colspan="1">Gene description</td>
                  <td colspan="2" align="left" rowspan="1">Fold change*</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">6 h</td>
                  <td align="left" rowspan="1" colspan="1">24 h</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">BAG3</td>
                  <td align="left" rowspan="1" colspan="1">BCL2-associated athanogene 3</td>
                  <td align="left" rowspan="1" colspan="1">2.12</td>
                  <td align="left" rowspan="1" colspan="1">1.91</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">BIRC5</td>
                  <td align="left" rowspan="1" colspan="1">Baculoviral IAP repeat-containing 5</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.59</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">BLID</td>
                  <td align="left" rowspan="1" colspan="1">BH3-like motif containing, cell death inducer</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.76</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.2</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DDIT4</td>
                  <td align="left" rowspan="1" colspan="1">DNA-damage-inducible transcript 4</td>
                  <td align="left" rowspan="1" colspan="1">2.15</td>
                  <td align="left" rowspan="1" colspan="1">2.62</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DEDD2</td>
                  <td align="left" rowspan="1" colspan="1">Death effector domain containing 2</td>
                  <td align="left" rowspan="1" colspan="1">1.64</td>
                  <td align="left" rowspan="1" colspan="1">1.89</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DFFA</td>
                  <td align="left" rowspan="1" colspan="1">DNA fragmentation factor, 45 kda, alpha polypeptide</td>
                  <td align="left" rowspan="1" colspan="1">1.15</td>
                  <td align="left" rowspan="1" colspan="1">1.45</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DLX2</td>
                  <td align="left" rowspan="1" colspan="1">Distal-less homeobox 2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.63</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">F3</td>
                  <td align="left" rowspan="1" colspan="1">Coagulation factor III (thromboplastin, tissue factor)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.56</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.8</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">FOSL1</td>
                  <td align="left" rowspan="1" colspan="1">FOS-like antigen 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.44</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">GABARAPL1</td>
                  <td align="left" rowspan="1" colspan="1">GABA(A) receptor-associated protein like 1</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.76</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HELLS</td>
                  <td align="left" rowspan="1" colspan="1">Helicase, lymphoid-specific</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.3</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.97</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HSPA1A, HSPA1B</td>
                  <td align="left" rowspan="1" colspan="1">Heat shock 70 kda protein 1A, heat shock 70 kda protein 1B</td>
                  <td align="left" rowspan="1" colspan="1">4.57</td>
                  <td align="left" rowspan="1" colspan="1">6.27</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IER3</td>
                  <td align="left" rowspan="1" colspan="1">Immediate early response 3</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.92</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.28</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IFI16</td>
                  <td align="left" rowspan="1" colspan="1">Interferon, gamma-inducible protein 16</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.15</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.01</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IGFBP3</td>
                  <td align="left" rowspan="1" colspan="1">Insulin-like growth factor binding protein 3</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.45</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.62</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IKBKE</td>
                  <td align="left" rowspan="1" colspan="1">Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.5</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.85</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">JMJD6</td>
                  <td align="left" rowspan="1" colspan="1">Jumonji domain containing 6</td>
                  <td align="left" rowspan="1" colspan="1">1.36</td>
                  <td align="left" rowspan="1" colspan="1">1.73</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">KLF10</td>
                  <td align="left" rowspan="1" colspan="1">Kruppel-like factor 10</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.24</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.1</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MYC</td>
                  <td align="left" rowspan="1" colspan="1">V-myc myelocytomatosis viral oncogene homolog (avian)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.31</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.63</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PDCD4, MIR4680</td>
                  <td align="left" rowspan="1" colspan="1">Programmed cell death 4 (neoplastic transformation inhibitor), microrna 4680</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.51</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SERPINB2, SERPINB10</td>
                  <td align="left" rowspan="1" colspan="1">Serpin peptidase inhibitor, clade B (ovalbumin), member 2 and member 10</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.87</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;5.52</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SFN</td>
                  <td align="left" rowspan="1" colspan="1">Stratifin</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.21</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.78</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SMAD6</td>
                  <td align="left" rowspan="1" colspan="1">SMAD family member 6</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.4</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SMAD7</td>
                  <td align="left" rowspan="1" colspan="1">SMAD family member 7</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.24</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.51</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SNAI2</td>
                  <td align="left" rowspan="1" colspan="1">Snail homolog 2 (Drosophila)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.59</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.49</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TGM2</td>
                  <td align="left" rowspan="1" colspan="1">Transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.99</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">THBS1</td>
                  <td align="left" rowspan="1" colspan="1">Thrombospondin 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.59</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.47</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
        </table-wrap>
        <p>In addition, the analysis also revealed significantly enriched Keap1-Nrf2 pathway (<italic>p-</italic>value&#x200A;=&#x200A;0.032, <xref ref-type="table" rid="pone-0096404-t003">Table 3</xref>) which suggested that the oxidative status of cells is altered. The apoptotic pathway is another significantly altered biological process that was observed (p-value&#x200A;=&#x200A;0.027, <xref ref-type="table" rid="pone-0096404-t003">Table 3</xref>). The list of differentially expressed genes related to apoptosis is summarized in <xref ref-type="table" rid="pone-0096404-t006">Table 6</xref>.</p>
        <p>To further identify the dysregulated biological processes, differential regulated genes were subjected to Gene Set Enrichment Analysis (GSEA). GSEA enabled us to determine whether a priori defined set of genes is statistically significantly (with nominal p-value &lt;0.05 and FDR&lt;0.25) enriched after treatment with ZEA. The detailed results are shown in <xref ref-type="supplementary-material" rid="pone.0096404.s006">Table S6</xref>. Interestingly, in addition to the pathways as identified by SEA, gene sets related to the extracellular matrix molecule tenascin C <xref rid="pone.0096404-Ruiz1" ref-type="bibr">[20]</xref>, histone deacetylation <xref rid="pone.0096404-Senese1" ref-type="bibr">[21]</xref> and estrogenic responses <xref rid="pone.0096404-Stein1" ref-type="bibr">[22]</xref> were also recognized to be enriched (<xref ref-type="fig" rid="pone-0096404-g003">Figure 3</xref>).</p>
        <fig id="pone-0096404-g003" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Analysis of the functional gene set enrichment after 24 h ZEA treatment by GSEA.</title>
            <p>Differential gene expression was ranked by fold change. The most up-regulated genes are shown on the left while the most down-regulated genes are shown on the right. The black vertical lines indicate where the genes in the signature get set appeared. (A) Genes that is down-regulated in the presence of extracellular matrix molecule Tenascin C. (B) Genes that are down-regulated upon knockdown of boh histone deacetylase (HDAC) 1 and 2. (C) Genes that are down-regulated by estradol and down-regulated by estrogen-related receptor alpha. Enrichment score (ES, Y axis) is a running-sum statistic showing if the prior defined set of genes are randomly distributed or found at the extremes (top or bottom) of the list. If the genes are overrepresented at the bottom of our ranked list of genes, the ES will be close to &#x2212;1 and vice versa. A normalized enrichment score (NES) takes into account the number of genes in the pathway. A negative NES indicates &#x201C;bottom&#x201D; enrichment of the list. The interpretation of the plots referred to <xref rid="pone.0096404-Subramanian1" ref-type="bibr">[61]</xref>.</p>
          </caption>
          <graphic xlink:href="pone.0096404.g003"/>
        </fig>
      </sec>
      <sec id="s3e">
        <title>ZEA induced oxidative stress in BEAS-2B cells</title>
        <p>The generation of ROS after treatment with ZEA was detected by flow cytometry. The fluorescence intensity in wild type cells that were exposed to 40 &#xB5;M ZEA for 6, 12, 24 and 48 h increased in a time-dependent manner by 18.4, 29.3, 28.0 and 25.1%, respectively (<xref ref-type="fig" rid="pone-0096404-g004">Figure 4A</xref>).</p>
        <fig id="pone-0096404-g004" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>Induction of oxidative stress in BEAS-2B cells by ZEA.</title>
            <p>(A) Levels of ROS in wild type and CYGB over-expressed cells detected by DCFH-DA probe using flow cytometry. Relative DCF+ levels (equivalent to intracellular ROS levels) were expressed as percentage increased compare to DMSO control. Bars with a and b denote significant differences in wild type whereas A,B and C reflect significant differences in CYGB over-expressed cells (One-way ANOVA, <italic>p</italic>&lt;0.05). *, ** and *** represent <italic>p</italic>&lt;0.05, <italic>p</italic>&lt;0.01 and <italic>p</italic>&lt;0.001 denoting significant differences from respective wild type values. The mRNA expression of oxidative stress related genes in BEAS-2B cells were quantified by real-time PCR. The mRNA expression of &#x3B2;&#x2013;actin was used for normalization. (B) Heat shock protein 70 (Hsp70). (C) Heat shock protein 27 (Hsp27). (D) Superoxide dismutase 2 (SOD2). (E) Catalase. Results represent the mean&#xB1; SD of at least 3 independent experiments. Bars with different alphabets are significant different (One-way ANOVA, <italic>p</italic>&lt;0.05).</p>
          </caption>
          <graphic xlink:href="pone.0096404.g004"/>
        </fig>
        <p>Concurred with the induction of ROS levels, the expressions of selected oxidative stress-related genes were up-regulated (<xref ref-type="fig" rid="pone-0096404-g004">Figure 4B-E</xref>). The up-regulation of heat shock protein 27 (Hsp27), superoxide dismutase (SOD2) and catalase were more pronounced at 6 h and their expression were increased by 2.86, 1.81 and 1.92 folds, respectively. Moreover, the expression of heat shock protein 70 (Hsp70) was dramatically increased by 41.98 folds and the up-regulation was maintained after 12 and 24 h treatment.</p>
      </sec>
      <sec id="s3f">
        <title>Over-expression of CYGB reduced ZEA-induced ROS generation and apoptosis in BEAS-2B cells</title>
        <p>Over-expression of CYGB, a free radical scavenger, was used to study the role of oxidative stress upon ZEA-induced cytotoxicity. Unlike the wild type BEAS-2B cells, the detection of significantly increased level of ROS was delayed to after 24 h and 48 h ZEA exposure. In addition, the level of induction was lowered to 14.0 and 23.9%, respectively (<xref ref-type="fig" rid="pone-0096404-g004">Figure 4A</xref>). These results suggested that over-expression of CYGB can attenuate and postpone the increase of ROS levels induced by ZEA.</p>
        <p>The detection of apoptotic cells was done by flow cytometry. Apoptotic cells were found in both wild type and CYGB-overexpressing cells after 24 and 48 h ZEA treatment (<xref ref-type="fig" rid="pone-0096404-g005">Figure 5</xref>). Over-expression of the endogenous free radcial scavenger, CYGB, conferred protective effects against ZEA-induced cell death. After ZEA exposure for 48 h, 13.68&#xB1;2.96% of wild type whilst 74.55&#xB1;0.78% of CYGB-overexpressing cells were still alive. On the other hand, 72.57&#xB1;2.61% of wild type whilst 13.95&#xB1;1.15% of CYGB-overexpressing cells underwent apoptosis and were at late apoptotic states.</p>
        <fig id="pone-0096404-g005" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.g005</object-id>
          <label>Figure 5</label>
          <caption>
            <title>Induction of apoptosis in BEAS-2B cells by ZEA.</title>
            <p>Early apoptotic cells stained with Annexin V are shown in lower right quadrant. Late apoptotic or necrotic cells are stained with both Annexin V and PI and are shown in upper right quadrant. Living cells are not stained and are shown in lower left quadrant. (A) 24 h wild type control. (B) 24 h wild type ZEA-treated. (C) 48 h wild type control. (D) 48 h wild type ZEA-treated. (E) 24 h CYGB over-expressed control. (F) 24 h CYGB over-expressed ZEA-treated. (G) 48 h CYGB over-expressed control. (H) 48 h CYGB over-expressed ZEA-treated.</p>
          </caption>
          <graphic xlink:href="pone.0096404.g005"/>
        </fig>
      </sec>
      <sec id="s3g">
        <title>Validation of differentially expressed genes by qPCR</title>
        <p>Disturbingly, many of the pro-inflammatory responsive genes were down-regulated while those anti-inflammatory genes were up-regulated (<xref ref-type="table" rid="pone-0096404-t007">Table 7</xref>). The anti-inflammatory effects of ZEA were further revealed in its ability to reduce lipopolysaccharide (LPS)-induced release of pro-inflammatory cytokines. After 6 h treatment, LPS alone induced the expressions of IL-6, IL-8 and IL-1&#x3B2; by 1.49, 1.37 and 1.29 folds, respectively. However, the inductions of these cytokines were significantly suppressed by ZEA (<xref ref-type="fig" rid="pone-0096404-g006">Figure 6</xref>).</p>
        <fig id="pone-0096404-g006" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.g006</object-id>
          <label>Figure 6</label>
          <caption>
            <title>Quantitative PCR showing mRNA expression of inflammatory cytokines and chemokines in LPS stimulated BEAS-2B cells.</title>
            <p>The mRNA expression of &#x3B2;&#x2013;actin was used for normalization. (A) Interleukin 6 (IL-6). (B) Interleukin 8 (IL-8). (C) Interleukin 1, beta (IL-1&#x3B2;). Results represent the mean&#xB1; SD of at least 3 independent experiments and bars with different alphabets show significant differences (One-way ANOVA, <italic>p</italic>&lt;0.05).</p>
          </caption>
          <graphic xlink:href="pone.0096404.g006"/>
        </fig>
        <table-wrap id="pone-0096404-t007" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.t007</object-id>
          <label>Table 7</label>
          <caption>
            <title>Differentially expressed genes related to inflammatory responses.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0096404-t007-7" xlink:href="pone.0096404.t007"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Gene symbol</td>
                  <td align="left" rowspan="1" colspan="1">Gene description</td>
                  <td colspan="2" align="left" rowspan="1">Fold change<xref ref-type="table-fn" rid="nt103">*</xref></td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">6 h</td>
                  <td align="left" rowspan="1" colspan="1">24 h</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ADAMTS1</td>
                  <td align="left" rowspan="1" colspan="1">ADAM metallopeptidase with thrombospondin type 1 motif, 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.29</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.32</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">BCL3</td>
                  <td align="left" rowspan="1" colspan="1">B-cell CLL/lymphoma 3</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.32</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.79</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">BMPER</td>
                  <td align="left" rowspan="1" colspan="1">BMP binding endothelial regulator</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.49</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.21</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CBLB</td>
                  <td align="left" rowspan="1" colspan="1">Cas-Br-M (murine) ecotropic retroviral transforming sequence b</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.56</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CCL2</td>
                  <td align="left" rowspan="1" colspan="1">Chemokine (C-C motif) ligand 2</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.57</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CD24</td>
                  <td align="left" rowspan="1" colspan="1">CD24 molecule</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.18</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CT45A5, CT45A2, CT45A3, CT45A6, CT45A4, CT45A1</td>
                  <td align="left" rowspan="1" colspan="1">Cancer/testis antigen family 45, member A5, cancer/testis antigen family 45, member A2, cancer/testis antigen family 45, member A3, cancer/testis antigen family 45, member A6, cancer/testis antigen family 45, member A4, cancer/testis antigen family 45, member A1</td>
                  <td align="left" rowspan="1" colspan="1">1.54</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CXCR7</td>
                  <td align="left" rowspan="1" colspan="1">Chemokine (C-X-C motif) receptor 7</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.28</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.68</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DKK1</td>
                  <td align="left" rowspan="1" colspan="1">Dickkopf WNT signaling pathway inhibitor 1</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.9</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">DUSP22</td>
                  <td align="left" rowspan="1" colspan="1">Dual specificity phosphatase 22</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.19</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.56</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">EDN1</td>
                  <td align="left" rowspan="1" colspan="1">Endothelin 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.57</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.53</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ELF4</td>
                  <td align="left" rowspan="1" colspan="1">E74-like factor 4 (ets domain transcription factor)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.54</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.54</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">F2RL2</td>
                  <td align="left" rowspan="1" colspan="1">Coagulation factor II (thrombin) receptor-like 2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.73</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;3.92</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">F3</td>
                  <td align="left" rowspan="1" colspan="1">Coagulation factor III (thromboplastin, tissue factor)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.56</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.8</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">FCER1G</td>
                  <td align="left" rowspan="1" colspan="1">Fc fragment of ige, high affinity I, receptor for; gamma polypeptide</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.77</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">FSTL3</td>
                  <td align="left" rowspan="1" colspan="1">Follistatin-like 3 (secreted glycoprotein)</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.46</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.87</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IFI16</td>
                  <td align="left" rowspan="1" colspan="1">Interferon, gamma-inducible protein 16</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.15</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.01</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IFIT1</td>
                  <td align="left" rowspan="1" colspan="1">Interferon-induced protein with tetratricopeptide repeats 1</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">2.29</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IFITM1</td>
                  <td align="left" rowspan="1" colspan="1">Interferon induced transmembrane protein 1 (9&#x2013;27)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.94</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IGHV4-31, IGHG1, IGHA1, <email>IGH@</email>, IGHJ2</td>
                  <td align="left" rowspan="1" colspan="1">Immunoglobulin heavy variable 4&#x2013;31, immunoglobulin heavy constant gamma 1 (G1m marker), immunoglobulin heavy constant alpha 1, immunoglobulin heavy locus, immunoglobulin heavy joining 2</td>
                  <td align="left" rowspan="1" colspan="1">1.64</td>
                  <td align="left" rowspan="1" colspan="1">1.17</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IGSF23</td>
                  <td align="left" rowspan="1" colspan="1">Immunoglobulin superfamily, member 23</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.12</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.66</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IGSF3</td>
                  <td align="left" rowspan="1" colspan="1">Immunoglobulin superfamily, member 3</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.26</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.62</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IKBKE</td>
                  <td align="left" rowspan="1" colspan="1">Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.5</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.85</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IL11</td>
                  <td align="left" rowspan="1" colspan="1">Interleukin 11</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">2.1</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IL1R1</td>
                  <td align="left" rowspan="1" colspan="1">Interleukin 1 receptor, type I</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.53</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IL27RA</td>
                  <td align="left" rowspan="1" colspan="1">Interleukin 27 receptor, alpha</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.45</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.68</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IL31RA</td>
                  <td align="left" rowspan="1" colspan="1">Interleukin 31 receptor A</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.18</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.52</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IL37</td>
                  <td align="left" rowspan="1" colspan="1">Interleukin 37</td>
                  <td align="left" rowspan="1" colspan="1">1.53</td>
                  <td align="left" rowspan="1" colspan="1">1.77</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IL6R</td>
                  <td align="left" rowspan="1" colspan="1">Interleukin 6 receptor</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.23</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.55</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IL7R</td>
                  <td align="left" rowspan="1" colspan="1">Interleukin 7 receptor</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.5</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.52</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IL8</td>
                  <td align="left" rowspan="1" colspan="1">Interleukin 8</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.22</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.7</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">IRAK4</td>
                  <td align="left" rowspan="1" colspan="1">Interleukin-1 receptor-associated kinase 4</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.13</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.69</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ITGB3</td>
                  <td align="left" rowspan="1" colspan="1">Integrin, beta 3 (platelet glycoprotein iiia, antigen CD61)</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.95</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">JUN</td>
                  <td align="left" rowspan="1" colspan="1">Jun proto-oncogene</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.35</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.67</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">KLF10</td>
                  <td align="left" rowspan="1" colspan="1">Kruppel-like factor 10</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.24</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.1</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">LAMC2</td>
                  <td align="left" rowspan="1" colspan="1">Laminin, gamma 2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.34</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.7</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">LRIG3</td>
                  <td align="left" rowspan="1" colspan="1">Leucine-rich repeats and immunoglobulin-like domains 3</td>
                  <td align="left" rowspan="1" colspan="1">1.19</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.75</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">LY6K</td>
                  <td align="left" rowspan="1" colspan="1">Lymphocyte antigen 6 complex, locus K</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.25</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.02</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">NCR3LG1</td>
                  <td align="left" rowspan="1" colspan="1">Natural killer cell cytotoxicity receptor 3 ligand 1</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.23</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.94</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">NOG</td>
                  <td align="left" rowspan="1" colspan="1">Noggin</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.95</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.35</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">OAS3</td>
                  <td align="left" rowspan="1" colspan="1">2'-5'-oligoadenylate synthetase 3, 100 kda</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.65</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">PLAU</td>
                  <td align="left" rowspan="1" colspan="1">Plasminogen activator, urokinase</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.79</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.6</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SEMA3C</td>
                  <td align="left" rowspan="1" colspan="1">Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.59</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SEMA3D</td>
                  <td align="left" rowspan="1" colspan="1">Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.18</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.65</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SMAD6</td>
                  <td align="left" rowspan="1" colspan="1">SMAD family member 6</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.4</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SMAD7</td>
                  <td align="left" rowspan="1" colspan="1">SMAD family member 7</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.24</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;2.51</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SMAD9</td>
                  <td align="left" rowspan="1" colspan="1">SMAD family member 9</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.5</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.58</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TGFB2</td>
                  <td align="left" rowspan="1" colspan="1">Transforming growth factor, beta 2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.2</td>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.75</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TGFBR1</td>
                  <td align="left" rowspan="1" colspan="1">Transforming growth factor, beta receptor 1</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&#x2212;1.51</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">TNFAIP8L1</td>
                  <td align="left" rowspan="1" colspan="1">Tumor necrosis factor, alpha-induced protein 8-like 1</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.88</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt103">
              <label/>
              <p>*Only the fold change with p&lt;0.05 are shown.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>After analyzing the microarray data, the expression changes of 10 selected genes including SERPINB2 and PLAU (apoptosis), CYP1B1 (aryl hydrocarbon receptor signaling), SMAD7 (TGF-&#x3B2; signaling), IL-8 and IL-37 (inflammatory response), JUN and EGR1 (regulation of transcription), CCNE2 (progression of cell cycle) and DDIT4 (response to DNA damage) were verified by quantitative real-time PCR (qPCR). The expression pattern (direction of regulation) showed a good agreement between the data of microarray and qPCR, although the fold-changes detected by qPCR appeared to be more pronounced (<xref ref-type="fig" rid="pone-0096404-g007">Figure 7</xref>).</p>
        <fig id="pone-0096404-g007" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.g007</object-id>
          <label>Figure 7</label>
          <caption>
            <title>Validation of the expressions of selected genes by real-time PCR.</title>
            <p>(A) 6 hr. (B) 24 hr. Real-time PCR results are represented as mean&#xB1; SD of at least 3 independent experiments</p>
          </caption>
          <graphic xlink:href="pone.0096404.g007"/>
        </fig>
      </sec>
      <sec id="s3h">
        <title>ZEA caused global DNA hypomethylation in BEAS-2B cells</title>
        <p>As shown in <xref ref-type="fig" rid="pone-0096404-g008">Figure 8</xref>, the level of global DNA methylation was significantly lowered to 40.3&#xB1;11.1% (<italic>p</italic>&lt;0.01) and 53.09&#xB1;33.75% (<italic>p</italic>&lt;0.01) relative to control in cells treated with 1 &#xB5;M 5-aza-cytidine or 40 &#xB5;M ZEA respectively. These results suggest that global DNA demethylation occurs when BEAS-2B cells are exposed to ZEA.</p>
        <fig id="pone-0096404-g008" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.g008</object-id>
          <label>Figure 8</label>
          <caption>
            <title>Induction of global DNA demethylation in BEAS-2B cells by exposure to ZEA for 24 h.</title>
            <p>Results represent the mean&#xB1; SD of at least 3 independent experiments and ** represents p&lt;0.01 significantly different from DMSO control values as assessed by t-test.</p>
          </caption>
          <graphic xlink:href="pone.0096404.g008"/>
        </fig>
      </sec>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>The aim of this study is to decipher the toxic effects and molecular mechanisms induced by ZEA in human bronchial epithelial cells (BEAS-2B). Our experiments and biological interpretation of the genome-wide transcriptome analysis indicated that induction of oxidative stress, arrest of cell cycle progression, initiation of apoptosis, suppression of inflammatory responses and changes of epigenetic marks are the consequences of exposure to ZEA.</p>
      <sec id="s4a">
        <title>Induction of oxidative stress by ZEA</title>
        <p>The broad range of toxic events provoked by ZEA is believed not solely due to the interaction with estrogen receptors but also through the induction of oxidative stress. Our results indicated that the Keap1-Nrf2 pathway was suppressed (<xref ref-type="table" rid="pone-0096404-t003">Table 3</xref>), as the levels of intracellular ROS was increased (<xref ref-type="fig" rid="pone-0096404-g004">Figure 4A</xref>) and the expression of free radical scavengers, SOD2 and catalase, were up-regulated (<xref ref-type="fig" rid="pone-0096404-g004">Figure 4D and E</xref>) after ZEA treatment. Nrf2 is a transcription factor that binds to the antioxidant responsive element at the regulatory region of target genes that confer protection against oxidative stress <xref rid="pone.0096404-Itoh1" ref-type="bibr">[23]</xref>. Nrf2 is normally sequestered and inhibited at the cytoplasm by Keap1. However, under stress conditions, Nrf2 dissociates from Keap1 and translocates to the nucleus to control gene expression <xref rid="pone.0096404-Itoh1" ref-type="bibr">[23]</xref>. The expression of SOD2 and catalase are up-regulated under oxidative stress by the binding of Nrf2 to their promoters <xref rid="pone.0096404-Numazawa1" ref-type="bibr">[24]</xref>. In addition, our results show dramatic up-regulation of heat shock proteins, which are early markers of oxidative stress <xref rid="pone.0096404-Arrigo1" ref-type="bibr">[25]</xref>, <xref rid="pone.0096404-Kiang1" ref-type="bibr">[26]</xref>.</p>
        <p>On the other hand, the generation of ROS (<xref ref-type="fig" rid="pone-0096404-g004">Figure 4A</xref>) and the induction of apoptosis (<xref ref-type="fig" rid="pone-0096404-g005">Figure 5</xref>) were significantly attenuated by the over expression of CYGB, a potent free radical scavenger. Collectively, our results suggest that ZEA is a strong inducer of ROS and oxidative stress is the underlying mediator of ZEA-induced cytotoxicity. These observations substantiate early reports showing that exogenous antioxidants including vitamin E and Tunisian radish protect against ZEA-induced oxidative damage and subsequent apoptosis <xref rid="pone.0096404-AbidEssefi2" ref-type="bibr">[27]</xref>, <xref rid="pone.0096404-SalahAbbs1" ref-type="bibr">[28]</xref>.</p>
        <p>The mechanism by which ZEA induces production of ROS is ambiguous. It is known that upon metabolism of ZEA, 3&#x3B1;-/3&#x3B2;-hydroxysteroid dehydrogenases catalyze the formation of two major reductive metabolites, &#x3B1;&#x2013; and &#x3B2;-Zearalenol <xref rid="pone.0096404-Olsen1" ref-type="bibr">[29]</xref>. Pfeiffer et al <xref rid="pone.0096404-Pfeiffer1" ref-type="bibr">[30]</xref> identified two highly unstable oxidative metabolites of ZEA, 13-hydroxy-ZEA and 15-hydroxy ZEA, which are demonstrated to possess the same potency for causing oxidative DNA damage (as measured by the level of 8-oxo-2&#x2032;-deoxyguanosine of DNA) as catechols of estradiols <xref rid="pone.0096404-Fleck1" ref-type="bibr">[31]</xref>. Therefore, we believe that ROS could be generated during the formation of these metabolites. In addition, ROS may be generated due to the alteration of mitochondrial NADPH-oxidase which functions to generate superoxide anions (O<sub>2</sub><sup>&#x2212;</sup>) from normal oxygen <xref rid="pone.0096404-Babior1" ref-type="bibr">[32]</xref>. Our array results support this supposition as the expression of NADPH-oxidase (NOX5) is up-regulated by 1.32 and 1.6 fold upon 6 and 24 h exposure to ZEA (<xref ref-type="supplementary-material" rid="pone.0096404.s002">Table S2</xref> and <xref ref-type="supplementary-material" rid="pone.0096404.s003">S3</xref>).</p>
      </sec>
      <sec id="s4b">
        <title>DNA damages and inhibition of DNA repair by ZEA</title>
        <p>Excessive generation of ROS can oxidize cellular macromolecules including DNA, protein and lipids. The ability of ZEA to cause oxidative DNA damage including DNA fragmentation, single- and double stranded breakage as well as formation of 8-oxoguanine were reported <xref rid="pone.0096404-Hassen1" ref-type="bibr">[9]</xref>, <xref rid="pone.0096404-AbidEssefi2" ref-type="bibr">[27]</xref>, <xref rid="pone.0096404-AbidEssefi3" ref-type="bibr">[33]</xref>. Our microarray results also signified the suppression of DNA repair and induction of DNA damage (<xref ref-type="table" rid="pone-0096404-t003">Table 3</xref> and <xref ref-type="table" rid="pone-0096404-t005">5</xref>). The expression of breast cancer 1, early onset (BRCA1), RAD51, bloom syndrome, RecQ helicase-like (BLM), flap-endonuclease 1 (FEN1), uracil-DNA glycosylase (UNG), damage-specific DNA binding protein 2 (DDB2) and exonuclease 1 (EXO1) were significantly suppressed after 24 h ZEA treatment (<xref ref-type="table" rid="pone-0096404-t005">Table 5</xref>).</p>
        <p>BRCA1 functions in response to the signal of DNA damage and transcriptionally control downstream effectors <xref rid="pone.0096404-Venkitaraman1" ref-type="bibr">[34]</xref>, <xref rid="pone.0096404-Xu1" ref-type="bibr">[35]</xref>. RAD51 and BLM are involved in the repair of DNA double-strand break through homologous recombination <xref rid="pone.0096404-Baumann1" ref-type="bibr">[36]</xref>, <xref rid="pone.0096404-Sung1" ref-type="bibr">[37]</xref>. BRCA1 and RAD51 also interact to control recombination and maintain the integrity of the genome <xref rid="pone.0096404-Scully1" ref-type="bibr">[38]</xref>. FEN1 <xref rid="pone.0096404-Klungland1" ref-type="bibr">[39]</xref>, UNG <xref rid="pone.0096404-Rada1" ref-type="bibr">[40]</xref>, DDB2 <xref rid="pone.0096404-Fitch1" ref-type="bibr">[41]</xref> and EXO1 <xref rid="pone.0096404-Tran1" ref-type="bibr">[42]</xref> are involved in DNA base-excision repair, DNA mismatch repair and homologous recombination. On the other hand, DNA-damage-inducible transcript 4 (DDIT4) and never in mitosis gene a-related kinase 2 (NEK2) which are involved in controlling DNA damage checkpoint and proper DNA repair, are significantly induced by 2.62 and 2.17 folds respectively after 24 h ZEA treatment (<xref ref-type="table" rid="pone-0096404-t005">Table 5</xref>). Our transcriptome analysis suggested that ZEA inhibited DNA repair and induced DNA damages.</p>
        <p>Our microarray data also revealed that the progression of cell cycle and replication of DNA in BEAS-2B cells was suppressed by ZEA (<xref ref-type="table" rid="pone-0096404-t004">Table 4</xref> and <xref ref-type="table" rid="pone-0096404-t005">5</xref>). The expressions of cyclin E (CCNE1, CCNE2), which are essential for S phase progression, are significantly down-regulated by 2.11 and 2.93 folds respectively while p21 activated kinase 3 (PAK3), a known inhibitor of Cdk4, is simultaneously induced by 1.91 folds after 24 h of ZEA treatment. These observations suggest that cyclinD/cdk4 and cyclinE/cdk2 complexes which are essential for G1/S cell cycle progression have been suppressed.</p>
      </sec>
      <sec id="s4c">
        <title>Arrest of cell cycle by ZEA</title>
        <p>In addition, many genes related to DNA replication, which are also essential for S phase progression, are down-regulated after 24 h of ZEA treatment (<xref ref-type="table" rid="pone-0096404-t005">Table 5</xref>). The essential components of the pre-replicative complex (pre-RC) including origin recognition complex, subunit 1 (ORC1), cell division cycle 6 (CDC6) and most member of minichromosome maintenance protein (MCM 2&#x2013;7) show decreased levels of expression (<xref ref-type="table" rid="pone-0096404-t005">Table 5</xref>). In addition, the assembly and activation complex comprising MCM 10, CDC45, replication factor C (activator 1) 2 (RFC2) and interaction with subunits of replicative polymerase, including polymerase (DNA directed), alpha 1 (POLA1), polymerase (DNA directed), epsilon 2 (POLE2) and primase, DNA, polypeptide 1 (PRIM1), are also down-regulated (<xref ref-type="table" rid="pone-0096404-t005">Table 5</xref>). DNA helicase B (HELB), which is involved in DNA synthesis, is down-regulated by 1.78 folds (<xref ref-type="table" rid="pone-0096404-t005">Table 5</xref>). From the above results, it can be concluded that ZEA directly affects the machinery for DNA replication and synthesis in BEAS-2B cells.</p>
        <p>Taken together, it is tempting to speculate that ZEA induces DNA damage and halts cell cycle at G1/S phase as attempts to repair the damage are unsuccessful. These findings are in agreement with earlier studies which reported that ZEA induced DNA fragmentation and cell cycle arrest <xref rid="pone.0096404-AbidEssefi2" ref-type="bibr">[27]</xref>, <xref rid="pone.0096404-AbidEssefi3" ref-type="bibr">[33]</xref>. The presence of irreparable DNA lesions may lead to the occurrence of subsequent apoptosis in the affected cells (<xref ref-type="fig" rid="pone-0096404-g009">Figure 9</xref>).</p>
        <fig id="pone-0096404-g009" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0096404.g009</object-id>
          <label>Figure 9</label>
          <caption>
            <title>Proposed mechanisms of apoptosis induced by ZEA in BEAS-2B cells.</title>
            <p>The expression changes of genes associated with the biological processes are indicated.</p>
          </caption>
          <graphic xlink:href="pone.0096404.g009"/>
        </fig>
      </sec>
      <sec id="s4d">
        <title>Down-regulation of inflammatory responses by ZEA</title>
        <p>Due to the large surface structure of the lung, its innate immune response is essential as the first line of defense to act against environmental particles, allergens and invasion of pathogens. The responses often include production of cytokines and chemokines to recruit inflammatory effector cells such as macrophages, neutrophils, eosinophils and lymphocytes <xref rid="pone.0096404-Schmal1" ref-type="bibr">[43]</xref>. Our results indicated that ZEA weakened the innate immune response to bacterial pathogens (LPS) in bronchial epithelial cells through down-regulating the expression of various inflammatory genes (<xref ref-type="fig" rid="pone-0096404-g006">Figure 6</xref> and <xref ref-type="table" rid="pone-0096404-t007">Table 7</xref>). The mechanism of this down-regulation is possibly through the inhibition of the toll-like receptor (TLR) signaling pathway (<xref ref-type="table" rid="pone-0096404-t003">Table 3</xref>). TLR is a cell surface member of the pattern recognition receptors (PRRs) which are essential as first line defense of the host's responses to allergens and pathogens <xref rid="pone.0096404-Akira1" ref-type="bibr">[44]</xref>, <xref rid="pone.0096404-Barton1" ref-type="bibr">[45]</xref>. IL-1 receptor-associated kinase 4 (IRAK4) is an intrinsic kinase which mediates inhibition of IL-1/TLR induced NF-&#x3BA;B activation <xref rid="pone.0096404-Akira1" ref-type="bibr">[44]</xref>. Upon activation and stimulation of TLRs, association of MyD88 recruits IRAK4 which in turn induces the phosphorylation of IRAK1 and triggers downstream activation of NF-&#x3BA;B <xref rid="pone.0096404-Akira1" ref-type="bibr">[44]</xref>. In our microarray results, the expression of both MyD88 and IRAK4 are respectively down-regulated by 1.45 and 1.69 folds, pointing to the upstream suppression of TLR signaling and subsequent activation of NF-&#x3BA;B.</p>
        <p>Both suppressive and inductive effects of ZEA on inflammatory responses have been reported <xref rid="pone.0096404-Marin1" ref-type="bibr">[46]</xref>, <xref rid="pone.0096404-Ruh1" ref-type="bibr">[47]</xref>, <xref rid="pone.0096404-SalahAbbs2" ref-type="bibr">[48]</xref> albeit with different models, dosage and duration of incubation with ZEA. Oxidative stress could trigger inflammation signals through activation of transcription regulators, NF-&#x3BA;B and AP-1 <xref rid="pone.0096404-Zhou1" ref-type="bibr">[49]</xref>. In our results, however, ZEA induced ROS generations but suppressed inflammatory responses. These observations could be explained by the suppression of NF-&#x3BA;B activation through inhibition of the TLR signaling Myd88-dependent pathway as aforementioned. The finding is consistent with earlier proteomic study in H295R cells showing possible suppression of NF-&#x3BA;B pathway after ZEA exposure <xref rid="pone.0096404-Busk1" ref-type="bibr">[50]</xref>. Importantly, our results also indicate that the expressions of JUN, FOSL1 and ATF3 which form the AP-1 transcription complex are significantly decreased (<xref ref-type="table" rid="pone-0096404-t007">Table 7</xref>) suggesting that the AP-1 activation is possibly inhibited by ZEA.</p>
        <p>These observations suggested that exposure to air-borne ZEA may increase susceptibility of bronchial epithelial cells to infections due to down-regulation of the expression of inflammatory cytokines and chemokines.</p>
      </sec>
      <sec id="s4e">
        <title>Potential epigenetic changes by ZEA</title>
        <p>On the other hand, GSEA of the array results indicated that the histone deacetylation pathway is altered (<xref ref-type="fig" rid="pone-0096404-g003">Figure 3</xref>). Histone deacetlyation is associated with pathogenesis of lung diseases. For example, in COPD, the progressive reduction of HDAC activity is linked to the severity of the disease <xref rid="pone.0096404-Hogg1" ref-type="bibr">[51]</xref>, <xref rid="pone.0096404-Ito1" ref-type="bibr">[52]</xref>, <xref rid="pone.0096404-Barnes1" ref-type="bibr">[53]</xref>. Methylated promoters are often coupled with regional histone deacetylation and contribute to transcriptional inactivation. Global hypomethylation was also observed in BEAS-2B cells incubated with ZEA (<xref ref-type="fig" rid="pone-0096404-g008">Figure 8</xref>). Possibly, the presence of 8-OHdG <xref rid="pone.0096404-Turk1" ref-type="bibr">[54]</xref>, <xref rid="pone.0096404-Weitzman1" ref-type="bibr">[55]</xref> and O<sup>6</sup>-methylguanine formed during ROS-induced DNA damage prevented the methylation of adjacent cytosine residues <xref rid="pone.0096404-Hepburn1" ref-type="bibr">[56]</xref>, <xref rid="pone.0096404-Tan1" ref-type="bibr">[57]</xref>, <xref rid="pone.0096404-Xiao1" ref-type="bibr">[58]</xref>. Disturbingly, global DNA hypomethylation is a feature of tumorigenesis <xref rid="pone.0096404-Ehrlich1" ref-type="bibr">[59]</xref>, <xref rid="pone.0096404-Ehrlich2" ref-type="bibr">[60]</xref>. The role of DNA hypomethylation in the development of cancer is still a paradox. Demethylation of DNA usually occurs at intragenic regions and at repetitive DNA sequences. Three mechanisms including causing instability of chromosome, reactivation of transposable elements and loss of imprinting are proposed <xref rid="pone.0096404-Ehrlich2" ref-type="bibr">[60]</xref>. More importantly, altered DNA methylation levels can be stably inherited during DNA replication and disturb subsequent generations. Our results raised the concern on long-lasting effect of ZEA to lung cells which required further investigation.</p>
      </sec>
    </sec>
    <sec id="s5">
      <title>Conclusions</title>
      <p>Our results clearly pointed out the diverse biological responses that ensued when BEAS-2B lung epithelial cells are exposure to ZEA. It also gives us an insight into the molecular mechanisms underlying the adverse consequences of air-borne ZEA. Disturbingly, our results suggested that exposure to ZEA may increase susceptibility of bronchial epithelial cells to diseases through i) the down-regulation of inflammatory cytokines and ii) demethylation of DNA which is a feature of lung carcinogenesis.</p>
    </sec>
    <sec sec-type="supplementary-material" id="s6">
      <title>Supporting Information</title>
      <supplementary-material content-type="local-data" id="pone.0096404.s001">
        <label>Table S1</label>
        <caption>
          <p>
            <bold>Primers used for real-time quantitative PCR.</bold>
          </p>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pone.0096404.s001.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0096404.s002">
        <label>Table S2</label>
        <caption>
          <p>
            <bold>The complete list of differentially expressed genes (fold change &gt;1.5, ANOVA p-value &lt;0.05) in BEAS-2B cells after 6 h treatment.</bold>
          </p>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pone.0096404.s002.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0096404.s003">
        <label>Table S3</label>
        <caption>
          <p>
            <bold>The complete list of differentially expressed genes (fold change &gt;1.5, ANOVA p-value &lt;0.05) in BEAS-2B cells after 24 h treatment.</bold>
          </p>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pone.0096404.s003.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0096404.s004">
        <label>Table S4</label>
        <caption>
          <p>
            <bold>Summary of the enriched gene ontology (GO) terms in BEAS-2B cells after 6 h treatment with ZEA.</bold>
          </p>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pone.0096404.s004.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0096404.s005">
        <label>Table S5</label>
        <caption>
          <p>
            <bold>Summary of the enriched gene ontology (GO) terms in BEAS-2B cells after 24 h treatment with ZEA.</bold>
          </p>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pone.0096404.s005.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0096404.s006">
        <label>Table S6</label>
        <caption>
          <p>
            <bold>Pathways enriched in BEAS-2B cells after 24 h treatment with ZEA.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
        <media xlink:href="pone.0096404.s006.doc">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>The work was supported by the Seed Funding Programme for Basic Research and CRCG grants for postgraduate students of the University of Hong Kong as well as funding from HKU School of Professional and Continuing Education (SPACE).</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pone.0096404-Caldwell1">
        <label>1</label>
        <mixed-citation publication-type="journal"><name><surname>Caldwell</surname><given-names>RW</given-names></name>, <name><surname>Tuite</surname><given-names>J</given-names></name>, <name><surname>Stob</surname><given-names>M</given-names></name>, <name><surname>Baldwin</surname><given-names>R</given-names></name> (<year>1970</year>) <article-title>Zearalenone production by Fusarium species</article-title>. <source>Applied microbiology</source><volume>20</volume>: <fpage>31</fpage>&#x2013;<lpage>34</lpage><pub-id pub-id-type="pmid">5456939</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Sweeney1">
        <label>2</label>
        <mixed-citation publication-type="journal"><name><surname>Sweeney</surname><given-names>MJ</given-names></name>, <name><surname>Dobson</surname><given-names>ADW</given-names></name> (<year>1998</year>) <article-title>Mycotoxin production by Aspergillus, Fusarium and Penicillium species</article-title>. <source>Int J Food Microbiol</source><volume>43</volume>: <fpage>141</fpage>&#x2013;<lpage>158</lpage><pub-id pub-id-type="pmid">9801191</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Zinedine1">
        <label>3</label>
        <mixed-citation publication-type="journal"><name><surname>Zinedine</surname><given-names>A</given-names></name>, <name><surname>Soriano</surname><given-names>JM</given-names></name>, <name><surname>Molto</surname><given-names>JC</given-names></name>, <name><surname>Ma es</surname><given-names>J</given-names></name> (<year>2007</year>) <article-title>Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: An oestrogenic mycotoxin</article-title>. <source>Food Chem Toxicol</source><volume>45</volume>: <fpage>1</fpage>&#x2013;<lpage>18</lpage><pub-id pub-id-type="pmid">17045381</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Chang1">
        <label>4</label>
        <mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>K</given-names></name>, <name><surname>Kurtz</surname><given-names>HJ</given-names></name>, <name><surname>Mirocha</surname><given-names>CJ</given-names></name> (<year>1979</year>) <article-title>Effects of the mycotoxin zearalenone on swine reproduction</article-title>. <source>Am J Vet Res</source><volume>40</volume>: <fpage>1260</fpage><pub-id pub-id-type="pmid">525929</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Minervini1">
        <label>5</label>
        <mixed-citation publication-type="journal"><name><surname>Minervini</surname><given-names>F</given-names></name>, <name><surname>Giannoccaro</surname><given-names>A</given-names></name>, <name><surname>Cavallini</surname><given-names>A</given-names></name>, <name><surname>Visconti</surname><given-names>A</given-names></name> (<year>2005</year>) <article-title>Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters</article-title>. <source>Toxicol Lett</source><volume>159</volume>: <fpage>272</fpage>&#x2013;<lpage>283</lpage><pub-id pub-id-type="pmid">15994033</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Ruzsas1">
        <label>6</label>
        <mixed-citation publication-type="journal"><name><surname>Ruzsas</surname><given-names>C</given-names></name>, <name><surname>Biro-Gosztonyi</surname><given-names>M</given-names></name>, <name><surname>W&#xF6;ller</surname><given-names>L</given-names></name>, <name><surname>Mess</surname><given-names>B</given-names></name> (<year>1979</year>) <article-title>Effect of the fungal toxin (zearalenone) on the reproductive system and fertility of male and female rats</article-title>. <source>Acta Biol Acad Sci Hung</source><volume>30</volume>: <fpage>335</fpage><pub-id pub-id-type="pmid">162329</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Sheehan1">
        <label>7</label>
        <mixed-citation publication-type="journal"><name><surname>Sheehan</surname><given-names>DM</given-names></name>, <name><surname>Branham</surname><given-names>WS</given-names></name>, <name><surname>Medlock</surname><given-names>KL</given-names></name>, <name><surname>Shanmugasundaram</surname><given-names>ERB</given-names></name> (<year>1984</year>) <article-title>Estrogenic activity of zearalenone and zearalanol in the neonatal rat uterus</article-title>. <source>Teratology</source><volume>29</volume>: <fpage>383</fpage>&#x2013;<lpage>392</lpage><pub-id pub-id-type="pmid">6235618</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-AbidEssefi1">
        <label>8</label>
        <mixed-citation publication-type="journal"><name><surname>Abid-Essefi</surname><given-names>S</given-names></name>, <name><surname>Zaied</surname><given-names>C</given-names></name>, <name><surname>Bouaziz</surname><given-names>C</given-names></name>, <name><surname>Salem</surname><given-names>IB</given-names></name>, <name><surname>Kaderi</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Protective effect of aqueous extract of Allium sativum against zearalenone toxicity mediated by oxidative stress</article-title>. <source>Exp Toxicol Pathol</source><volume>64</volume>: <fpage>689</fpage>&#x2013;<lpage>695</lpage><pub-id pub-id-type="pmid">21288705</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Hassen1">
        <label>9</label>
        <mixed-citation publication-type="journal"><name><surname>Hassen</surname><given-names>W</given-names></name>, <name><surname>Ayed-Boussema</surname><given-names>I</given-names></name>, <name><surname>Oscoz</surname><given-names>AA</given-names></name>, <name><surname>De Cerain Lopez</surname><given-names>A</given-names></name>, <name><surname>Bacha</surname><given-names>H</given-names></name> (<year>2007</year>) <article-title>The role of oxidative stress in zearalenone-mediated toxicity in Hep G2 cells: Oxidative DNA damage, gluthatione depletion and stress proteins induction</article-title>. <source>Toxicology</source><volume>232</volume>: <fpage>294</fpage>&#x2013;<lpage>302</lpage><pub-id pub-id-type="pmid">17339071</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-SalahAbbes1">
        <label>10</label>
        <mixed-citation publication-type="journal"><name><surname>Salah-Abbes</surname><given-names>JB</given-names></name>, <name><surname>Abbes</surname><given-names>S</given-names></name>, <name><surname>Ouanes</surname><given-names>Z</given-names></name>, <name><surname>Houas</surname><given-names>Z</given-names></name>, <name><surname>Abdel-Wahhab</surname><given-names>MA</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Tunisian radish extract (Raphanus sativus) enhances the antioxidant status and protects against oxidative stress induced by zearalenone in Balb/c mice</article-title>. <source>J Appl Toxicol</source><volume>28</volume>: <fpage>6</fpage>&#x2013;<lpage>14</lpage><pub-id pub-id-type="pmid">17385802</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Dornbusch1">
        <label>11</label>
        <mixed-citation publication-type="journal"><name><surname>Dornbusch</surname><given-names>HJ</given-names></name>, <name><surname>Buzina</surname><given-names>W</given-names></name>, <name><surname>Summerbell</surname><given-names>RC</given-names></name>, <name><surname>Lass-Fl&#xF6;rl</surname><given-names>C</given-names></name>, <name><surname>Lackner</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Fusarium verticillioides abscess of the nasal septum in an immunosuppressed child: case report and identification of the morphologically atypical fungal strain</article-title>. <source>J Clin Microbiol</source><volume>43</volume>: <fpage>1998</fpage>&#x2013;<lpage>2001</lpage><pub-id pub-id-type="pmid">15815043</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Yan1">
        <label>12</label>
        <mixed-citation publication-type="journal"><name><surname>Yan</surname><given-names>X</given-names></name>, <name><surname>Yu</surname><given-names>C</given-names></name>, <name><surname>Shi</surname><given-names>Z</given-names></name>, <name><surname>Wang</surname><given-names>S</given-names></name>, <name><surname>Zhang</surname><given-names>F</given-names></name> (<year>2013</year>) <article-title>Nasal Cutaneous Infection in a healthy boy caused by Fusarium moniliforme</article-title>. <source>Pediatr Dermatol</source><volume>30</volume>: <fpage>e43</fpage>&#x2013;<lpage>45</lpage><pub-id pub-id-type="pmid">23360372</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Tangni1">
        <label>13</label>
        <mixed-citation publication-type="journal"><name><surname>Tangni</surname><given-names>EK</given-names></name>, <name><surname>Pussemier</surname><given-names>L</given-names></name> (<year>2007</year>) <article-title>Ergosterol and mycotoxins in grain dusts from fourteen Belgian cereal storages: A preliminary screening survey</article-title>. <source>J Sci Food Agric</source><volume>87</volume>: <fpage>1263</fpage>&#x2013;<lpage>1270</lpage></mixed-citation>
      </ref>
      <ref id="pone.0096404-Wang1">
        <label>14</label>
        <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Chai</surname><given-names>T</given-names></name>, <name><surname>Lu</surname><given-names>G</given-names></name>, <name><surname>Quan</surname><given-names>C</given-names></name>, <name><surname>Duan</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Simultaneous detection of airborne Aflatoxin, Ochratoxin and Zearalenone in a poultry house by immunoaffinity clean-up and high-performance liquid chromatography</article-title>. <source>Env Res</source><volume>107</volume>: <fpage>139</fpage>&#x2013;<lpage>144</lpage><pub-id pub-id-type="pmid">18313042</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-MrquezGarbn1">
        <label>15</label>
        <mixed-citation publication-type="journal"><name><surname>M&#xE1;rquez-Garb&#xE1;n</surname><given-names>DC</given-names></name>, <name><surname>Chen</surname><given-names>H-W</given-names></name>, <name><surname>Fishbein</surname><given-names>MC</given-names></name>, <name><surname>Goodglick</surname><given-names>L</given-names></name>, <name><surname>Pietras</surname><given-names>RJ</given-names></name> (<year>2007</year>) <article-title>Estrogen receptor signaling pathways in human non-small cell lung cancer</article-title>. <source>Steroids</source><volume>72</volume>: <fpage>135</fpage>&#x2013;<lpage>143</lpage><pub-id pub-id-type="pmid">17276470</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Siegfried1">
        <label>16</label>
        <mixed-citation publication-type="journal"><name><surname>Siegfried</surname><given-names>JM</given-names></name> (<year>2001</year>) <article-title>Women and lung cancer: does oestrogen play a role?</article-title><source>Lancet Oncol</source><volume>2</volume>: <fpage>506</fpage><pub-id pub-id-type="pmid">11905727</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Cavalieri1">
        <label>17</label>
        <mixed-citation publication-type="journal"><name><surname>Cavalieri</surname><given-names>E</given-names></name>, <name><surname>Rogan</surname><given-names>E</given-names></name> (<year>2006</year>) <article-title>Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers</article-title>. <source>Ann N Y Acad Sci</source><volume>1089</volume>: <fpage>286</fpage>&#x2013;<lpage>301</lpage><pub-id pub-id-type="pmid">17261777</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Tam1">
        <label>18</label>
        <mixed-citation publication-type="journal"><name><surname>Tam</surname><given-names>A</given-names></name>, <name><surname>Morrish</surname><given-names>D</given-names></name>, <name><surname>Wadsworth</surname><given-names>S</given-names></name>, <name><surname>Dorscheid</surname><given-names>D</given-names></name>, <name><surname>Man</surname><given-names>SP</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>The role of female hormones on lung function in chronic lung diseases</article-title>. <source>BMC Womens Health</source><volume>11</volume>: <fpage>24</fpage><pub-id pub-id-type="pmid">21639909</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Reddel1">
        <label>19</label>
        <mixed-citation publication-type="journal"><name><surname>Reddel</surname><given-names>RR</given-names></name>, <name><surname>Ke</surname><given-names>Y</given-names></name>, <name><surname>Gerwin</surname><given-names>BI</given-names></name>, <name><surname>McMenamin</surname><given-names>MG</given-names></name>, <name><surname>Lechner</surname><given-names>JF</given-names></name>, <etal>et al</etal> (<year>1988</year>) <article-title>Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes</article-title>. <source>Cancer Res</source><volume>48</volume>: <fpage>1904</fpage>&#x2013;<lpage>1909</lpage><pub-id pub-id-type="pmid">2450641</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Ruiz1">
        <label>20</label>
        <mixed-citation publication-type="journal"><name><surname>Ruiz</surname><given-names>C</given-names></name>, <name><surname>Huang</surname><given-names>W</given-names></name>, <name><surname>Hegi</surname><given-names>ME</given-names></name>, <name><surname>Lange</surname><given-names>K</given-names></name>, <name><surname>Hamou</surname><given-names>M-F</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Differential gene expression analysis reveals activation of growth promoting signaling pathways by tenascin-C</article-title>. <source>Cancer Res</source><volume>64</volume>: <fpage>7377</fpage>&#x2013;<lpage>7385</lpage><pub-id pub-id-type="pmid">15492259</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Senese1">
        <label>21</label>
        <mixed-citation publication-type="journal"><name><surname>Senese</surname><given-names>S</given-names></name>, <name><surname>Zaragoza</surname><given-names>K</given-names></name>, <name><surname>Minardi</surname><given-names>S</given-names></name>, <name><surname>Muradore</surname><given-names>I</given-names></name>, <name><surname>Ronzoni</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Role for histone deacetylase 1 in human tumor cell proliferation</article-title>. <source>Mol Cell Biol</source><volume>27</volume>: <fpage>4784</fpage>&#x2013;<lpage>4795</lpage><pub-id pub-id-type="pmid">17470557</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Stein1">
        <label>22</label>
        <mixed-citation publication-type="journal"><name><surname>Stein</surname><given-names>RA</given-names></name>, <name><surname>Chang</surname><given-names>C-y</given-names></name>, <name><surname>Kazmin</surname><given-names>DA</given-names></name>, <name><surname>Way</surname><given-names>J</given-names></name>, <name><surname>Schroeder</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Estrogen-Related Receptor &#x3B1; Is Critical for the Growth of Estrogen Receptor&#x2013;Negative Breast Cancer</article-title>. <source>Cancer Res</source><volume>68</volume>: <fpage>8805</fpage>&#x2013;<lpage>8812</lpage><pub-id pub-id-type="pmid">18974123</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Itoh1">
        <label>23</label>
        <mixed-citation publication-type="journal"><name><surname>Itoh</surname><given-names>K</given-names></name>, <name><surname>Chiba</surname><given-names>T</given-names></name>, <name><surname>Takahashi</surname><given-names>S</given-names></name>, <name><surname>Ishii</surname><given-names>T</given-names></name>, <name><surname>Igarashi</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>1997</year>) <article-title>An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements</article-title>. <source>Biochem Biophys Res Commun</source><volume>236</volume>: <fpage>313</fpage>&#x2013;<lpage>322</lpage><pub-id pub-id-type="pmid">9240432</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Numazawa1">
        <label>24</label>
        <mixed-citation publication-type="journal"><name><surname>Numazawa</surname><given-names>S</given-names></name>, <name><surname>Yoshida</surname><given-names>T</given-names></name> (<year>2004</year>) <article-title>Nrf2-dependent gene expressions: a molecular toxicological aspect</article-title>. <source>J Toxicol Sci</source><volume>29</volume>: <fpage>81</fpage>&#x2013;<lpage>89</lpage><pub-id pub-id-type="pmid">15206576</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Arrigo1">
        <label>25</label>
        <mixed-citation publication-type="journal"><name><surname>Arrigo</surname><given-names>AP</given-names></name>, <name><surname>Firdaus</surname><given-names>WJJ</given-names></name>, <name><surname>Mellier</surname><given-names>G</given-names></name>, <name><surname>Moulin</surname><given-names>M</given-names></name>, <name><surname>Paul</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Cytotoxic effects induced by oxidative stress in cultured mammalian cells and protection provided by Hsp27 expression</article-title>. <source>Methods</source><volume>35</volume>: <fpage>126</fpage>&#x2013;<lpage>138</lpage><pub-id pub-id-type="pmid">15649839</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Kiang1">
        <label>26</label>
        <mixed-citation publication-type="journal"><name><surname>Kiang</surname><given-names>JG</given-names></name>, <name><surname>Tsokos</surname><given-names>GC</given-names></name> (<year>1998</year>) <article-title>Heat Shock Protein 70 kDa* 1:: Molecular Biology, Biochemistry, and Physiology</article-title>. <source>Pharmacol Ther</source><volume>80</volume>: <fpage>183</fpage>&#x2013;<lpage>201</lpage><pub-id pub-id-type="pmid">9839771</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-AbidEssefi2">
        <label>27</label>
        <mixed-citation publication-type="journal"><name><surname>Abid-Essefi</surname><given-names>S</given-names></name>, <name><surname>Baudrimont</surname><given-names>I</given-names></name>, <name><surname>Hassen</surname><given-names>W</given-names></name>, <name><surname>Ouanes</surname><given-names>Z</given-names></name>, <name><surname>Mobio</surname><given-names>TA</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>DNA fragmentation, apoptosis and cell cycle arrest induced by zearalenone in cultured DOK, Vero and Caco-2 cells: prevention by Vitamin E</article-title>. <source>Toxicology</source><volume>192</volume>: <fpage>237</fpage>&#x2013;<lpage>248</lpage><pub-id pub-id-type="pmid">14580790</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-SalahAbbs1">
        <label>28</label>
        <mixed-citation publication-type="journal"><name><surname>Salah-Abb&#xE8;s</surname><given-names>JB</given-names></name>, <name><surname>Abb&#xE8;s</surname><given-names>S</given-names></name>, <name><surname>Abdel-Wahhab</surname><given-names>MA</given-names></name>, <name><surname>Oueslati</surname><given-names>R</given-names></name> (<year>2010</year>) <article-title>In-vitro free radical scavenging, antiproliferative and anti-zearalenone cytotoxic effects of 4- (methylthio) -3-butenyl isothiocyanate from Tunisian Raphanus sativus</article-title>. <source>J Pharm Pharmacol</source><volume>62</volume>: <fpage>231</fpage>&#x2013;<lpage>239</lpage><pub-id pub-id-type="pmid">20487203</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Olsen1">
        <label>29</label>
        <mixed-citation publication-type="other">Olsen M (1989) Metabolism of zearalenone in farm animals. Topics in Secondary Metabolism.</mixed-citation>
      </ref>
      <ref id="pone.0096404-Pfeiffer1">
        <label>30</label>
        <mixed-citation publication-type="journal"><name><surname>Pfeiffer</surname><given-names>E</given-names></name>, <name><surname>Hildebrand</surname><given-names>A</given-names></name>, <name><surname>Damm</surname><given-names>G</given-names></name>, <name><surname>Rapp</surname><given-names>A</given-names></name>, <name><surname>Cramer</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Aromatic hydroxylation is a major metabolic pathway of the mycotoxin zearalenone in vitro</article-title>. <source>Mol Nutr Food Res</source><volume>53</volume>: <fpage>1123</fpage>&#x2013;<lpage>1133</lpage><pub-id pub-id-type="pmid">19655315</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Fleck1">
        <label>31</label>
        <mixed-citation publication-type="journal"><name><surname>Fleck</surname><given-names>SC</given-names></name>, <name><surname>Hildebrand</surname><given-names>AA</given-names></name>, <name><surname>M&#xFC;ller</surname><given-names>E</given-names></name>, <name><surname>Pfeiffer</surname><given-names>E</given-names></name>, <name><surname>Metzler</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Genotoxicity and inactivation of catechol metabolites of the mycotoxin zearalenone</article-title>. <source>Mycotoxin Res</source><volume>28</volume>: <fpage>267</fpage>&#x2013;<lpage>273</lpage><pub-id pub-id-type="pmid">23606198</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Babior1">
        <label>32</label>
        <mixed-citation publication-type="journal"><name><surname>Babior</surname><given-names>BM</given-names></name> (<year>1999</year>) <article-title>NADPH oxidase: an update</article-title>. <source>Blood</source><volume>93</volume>: <fpage>1464</fpage>&#x2013;<lpage>1476</lpage><pub-id pub-id-type="pmid">10029572</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-AbidEssefi3">
        <label>33</label>
        <mixed-citation publication-type="journal"><name><surname>Abid-Essefi</surname><given-names>S</given-names></name>, <name><surname>Ouanes</surname><given-names>Z</given-names></name>, <name><surname>Hassen</surname><given-names>W</given-names></name>, <name><surname>Baudrimont</surname><given-names>I</given-names></name>, <name><surname>Creppy</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Cytotoxicity, inhibition of DNA and protein syntheses and oxidative damage in cultured cells exposed to zearalenone</article-title>. <source>Toxicol In Vitro</source><volume>18</volume>: <fpage>467</fpage>&#x2013;<lpage>474</lpage><pub-id pub-id-type="pmid">15130604</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Venkitaraman1">
        <label>34</label>
        <mixed-citation publication-type="journal"><name><surname>Venkitaraman</surname><given-names>AR</given-names></name> (<year>2002</year>) <article-title>Cancer susceptibility and the functions of BRCA1 and BRCA2</article-title>. <source>Cell</source><volume>108</volume>: <fpage>171</fpage>&#x2013;<lpage>182</lpage><pub-id pub-id-type="pmid">11832208</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Xu1">
        <label>35</label>
        <mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>B</given-names></name>, <name><surname>Kim</surname><given-names>S-t</given-names></name>, <name><surname>Kastan</surname><given-names>MB</given-names></name> (<year>2001</year>) <article-title>Involvement of Brca1 in S-phase and G2-phase checkpoints after ionizing irradiation</article-title>. <source>Mol Cell Biol</source><volume>21</volume>: <fpage>3445</fpage>&#x2013;<lpage>3450</lpage><pub-id pub-id-type="pmid">11313470</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Baumann1">
        <label>36</label>
        <mixed-citation publication-type="journal"><name><surname>Baumann</surname><given-names>P</given-names></name>, <name><surname>Benson</surname><given-names>FE</given-names></name>, <name><surname>West</surname><given-names>SC</given-names></name> (<year>1996</year>) <article-title>Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro</article-title>. <source>Cell</source><volume>87</volume>: <fpage>757</fpage>&#x2013;<lpage>766</lpage><pub-id pub-id-type="pmid">8929543</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Sung1">
        <label>37</label>
        <mixed-citation publication-type="journal"><name><surname>Sung</surname><given-names>P</given-names></name>, <name><surname>Robberson</surname><given-names>DL</given-names></name> (<year>1995</year>) <article-title>DNA strand exchange mediated by a RAD51-ssDNA nucleoprotein filament with polarity opposite to that of RecA</article-title>. <source>Cell</source><volume>82</volume>: <fpage>453</fpage>&#x2013;<lpage>461</lpage><pub-id pub-id-type="pmid">7634335</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Scully1">
        <label>38</label>
        <mixed-citation publication-type="journal"><name><surname>Scully</surname><given-names>R</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Plug</surname><given-names>A</given-names></name>, <name><surname>Xiao</surname><given-names>Y</given-names></name>, <name><surname>Weaver</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>1997</year>) <article-title>Association of BRCA1 with Rad51 in mitotic and meiotic cells</article-title>. <source>Cell</source><volume>88</volume>: <fpage>265</fpage>&#x2013;<lpage>275</lpage><pub-id pub-id-type="pmid">9008167</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Klungland1">
        <label>39</label>
        <mixed-citation publication-type="journal"><name><surname>Klungland</surname><given-names>A</given-names></name>, <name><surname>Lindahl</surname><given-names>T</given-names></name> (<year>1997</year>) <article-title>Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1)</article-title>. <source>EMBO J</source><volume>16</volume>: <fpage>3341</fpage>&#x2013;<lpage>3348</lpage><pub-id pub-id-type="pmid">9214649</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Rada1">
        <label>40</label>
        <mixed-citation publication-type="journal"><name><surname>Rada</surname><given-names>C</given-names></name>, <name><surname>Williams</surname><given-names>GT</given-names></name>, <name><surname>Nilsen</surname><given-names>H</given-names></name>, <name><surname>Barnes</surname><given-names>DE</given-names></name>, <name><surname>Lindahl</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice</article-title>. <source>Curr Biol</source><volume>12</volume>: <fpage>1748</fpage>&#x2013;<lpage>1755</lpage><pub-id pub-id-type="pmid">12401169</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Fitch1">
        <label>41</label>
        <mixed-citation publication-type="journal"><name><surname>Fitch</surname><given-names>ME</given-names></name>, <name><surname>Nakajima</surname><given-names>S</given-names></name>, <name><surname>Yasui</surname><given-names>A</given-names></name>, <name><surname>Ford</surname><given-names>JM</given-names></name> (<year>2003</year>) <article-title>In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product</article-title>. <source>J Biol Chem</source><volume>278</volume>: <fpage>46906</fpage>&#x2013;<lpage>46910</lpage><pub-id pub-id-type="pmid">12944386</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Tran1">
        <label>42</label>
        <mixed-citation publication-type="journal"><name><surname>Tran</surname><given-names>PT</given-names></name>, <name><surname>Erdeniz</surname><given-names>N</given-names></name>, <name><surname>Symington</surname><given-names>LS</given-names></name>, <name><surname>Liskay</surname><given-names>RM</given-names></name> (<year>2004</year>) <article-title>EXO1-A multi-tasking eukaryotic nuclease</article-title>. <source>DNA repair (Amst)</source><volume>3</volume>: <fpage>1549</fpage>&#x2013;<lpage>1559</lpage><pub-id pub-id-type="pmid">15474417</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Schmal1">
        <label>43</label>
        <mixed-citation publication-type="journal"><name><surname>Schmal</surname><given-names>H</given-names></name>, <name><surname>Shanley</surname><given-names>TP</given-names></name>, <name><surname>Jones</surname><given-names>ML</given-names></name>, <name><surname>Friedl</surname><given-names>HP</given-names></name>, <name><surname>Ward</surname><given-names>PA</given-names></name> (<year>1996</year>) <article-title>Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats</article-title>. <source>J Immunol</source><volume>156</volume>: <fpage>1963</fpage>&#x2013;<lpage>1972</lpage><pub-id pub-id-type="pmid">8596051</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Akira1">
        <label>44</label>
        <mixed-citation publication-type="journal"><name><surname>Akira</surname><given-names>S</given-names></name>, <name><surname>Takeda</surname><given-names>K</given-names></name> (<year>2004</year>) <article-title>Toll-like receptor signalling</article-title>. <source>Nat Rev Immunol</source><volume>4</volume>: <fpage>499</fpage>&#x2013;<lpage>511</lpage><pub-id pub-id-type="pmid">15229469</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Barton1">
        <label>45</label>
        <mixed-citation publication-type="journal"><name><surname>Barton</surname><given-names>GM</given-names></name>, <name><surname>Medzhitov</surname><given-names>R</given-names></name> (<year>2003</year>) <article-title>Toll-like receptor signaling pathways</article-title>. <source>Science</source><volume>300</volume>: <fpage>1524</fpage>&#x2013;<lpage>1525</lpage><pub-id pub-id-type="pmid">12791976</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Marin1">
        <label>46</label>
        <mixed-citation publication-type="journal"><name><surname>Marin</surname><given-names>DE</given-names></name>, <name><surname>Taranu</surname><given-names>I</given-names></name>, <name><surname>Burlacu</surname><given-names>R</given-names></name>, <name><surname>Tudor</surname><given-names>DS</given-names></name> (<year>2010</year>) <article-title>Effects of zearalenone and its derivatives on the innate immune response of swine</article-title>. <source>Toxicon</source><volume>56</volume>: <fpage>956</fpage>&#x2013;<lpage>963</lpage><pub-id pub-id-type="pmid">20615424</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Ruh1">
        <label>47</label>
        <mixed-citation publication-type="journal"><name><surname>Ruh</surname><given-names>MF</given-names></name>, <name><surname>Bi</surname><given-names>Y</given-names></name>, <name><surname>Cox</surname><given-names>L</given-names></name>, <name><surname>Berk</surname><given-names>D</given-names></name>, <name><surname>Howlett</surname><given-names>AC</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Effect of environmental estrogens on IL-1&#x3B2; promoter activity in a macrophage cell line</article-title>. <source>Endocrine</source><volume>9</volume>: <fpage>207</fpage>&#x2013;<lpage>211</lpage><pub-id pub-id-type="pmid">9867255</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-SalahAbbs2">
        <label>48</label>
        <mixed-citation publication-type="journal"><name><surname>Salah-Abb&#xE8;s</surname><given-names>JB</given-names></name>, <name><surname>Abb&#xE8;s</surname><given-names>S</given-names></name>, <name><surname>Houas</surname><given-names>Z</given-names></name>, <name><surname>Abdel-Wahhab</surname><given-names>MA</given-names></name>, <name><surname>Oueslati</surname><given-names>R</given-names></name> (<year>2008</year>) <article-title>Zearalenone induces immunotoxicity in mice: possible protective effects of radish extract (Raphanus sativus)</article-title>. <source>J Pharm Pharmacol</source><volume>60</volume>: <fpage>761</fpage>&#x2013;<lpage>770</lpage><pub-id pub-id-type="pmid">18498713</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Zhou1">
        <label>49</label>
        <mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>L</given-names></name>, <name><surname>Tan</surname><given-names>A</given-names></name>, <name><surname>Iasvovskaia</surname><given-names>S</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Lin</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Ras and Mitogen-Activated Protein Kinase Kinase Kinase-1 Coregulate Activator Protein-1&#x2013;and Nuclear Factor-&#x3BA;B&#x2013;Mediated Gene Expression in Airway Epithelial Cells</article-title>. <source>Am J Respir Cell Mol Biol</source><volume>28</volume>: <fpage>762</fpage>&#x2013;<lpage>769</lpage><pub-id pub-id-type="pmid">12600818</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Busk1">
        <label>50</label>
        <mixed-citation publication-type="journal"><name><surname>Busk</surname><given-names>&#xD8;L</given-names></name>, <name><surname>Ndossi</surname><given-names>D</given-names></name>, <name><surname>Verhaegen</surname><given-names>S</given-names></name>, <name><surname>Connolly</surname><given-names>L</given-names></name>, <name><surname>Eriksen</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Relative quantification of the proteomic changes associated with the mycotoxin zearalenone in the H295R steroidogenesis model</article-title>. <source>Toxicon</source><volume>58</volume>: <fpage>533</fpage>&#x2013;<lpage>542</lpage><pub-id pub-id-type="pmid">21907227</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Hogg1">
        <label>51</label>
        <mixed-citation publication-type="journal"><name><surname>Hogg</surname><given-names>JC</given-names></name>, <name><surname>Chu</surname><given-names>F</given-names></name>, <name><surname>Utokaparch</surname><given-names>S</given-names></name>, <name><surname>Woods</surname><given-names>R</given-names></name>, <name><surname>Elliott</surname><given-names>WM</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>The nature of small-airway obstruction in chronic obstructive pulmonary disease</article-title>. <source>N Engl J Med</source><volume>350</volume>: <fpage>2645</fpage>&#x2013;<lpage>2653</lpage><pub-id pub-id-type="pmid">15215480</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Ito1">
        <label>52</label>
        <mixed-citation publication-type="journal"><name><surname>Ito</surname><given-names>K</given-names></name>, <name><surname>Ito</surname><given-names>M</given-names></name>, <name><surname>Elliott</surname><given-names>WM</given-names></name>, <name><surname>Cosio</surname><given-names>B</given-names></name>, <name><surname>Caramori</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Decreased histone deacetylase activity in chronic obstructive pulmonary disease</article-title>. <source>N Engl J Med</source><volume>352</volume>: <fpage>1967</fpage>&#x2013;<lpage>1976</lpage><pub-id pub-id-type="pmid">15888697</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Barnes1">
        <label>53</label>
        <mixed-citation publication-type="journal"><name><surname>Barnes</surname><given-names>PJ</given-names></name> (<year>2006</year>) <article-title>Reduced histone deacetylase in COPD: clinical implications</article-title>. <source>Chest</source><volume>129</volume>: <fpage>151</fpage>&#x2013;<lpage>155</lpage><pub-id pub-id-type="pmid">16424426</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Turk1">
        <label>54</label>
        <mixed-citation publication-type="journal"><name><surname>Turk</surname><given-names>PW</given-names></name>, <name><surname>Laayoun</surname><given-names>A</given-names></name>, <name><surname>Smith</surname><given-names>SS</given-names></name>, <name><surname>Weitzman</surname><given-names>SA</given-names></name> (<year>1995</year>) <article-title>DNA adduct 8-hydroxyl-2&#x2032;-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase</article-title>. <source>Carcinogenesis</source><volume>16</volume>: <fpage>1253</fpage>&#x2013;<lpage>1255</lpage><pub-id pub-id-type="pmid">7767994</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Weitzman1">
        <label>55</label>
        <mixed-citation publication-type="journal"><name><surname>Weitzman</surname><given-names>SA</given-names></name>, <name><surname>Turk</surname><given-names>PW</given-names></name>, <name><surname>Milkowski</surname><given-names>DH</given-names></name>, <name><surname>Kozlowski</surname><given-names>K</given-names></name> (<year>1994</year>) <article-title>Free radical adducts induce alterations in DNA cytosine methylation</article-title>. <source>Proc Natl Acad Sci USA</source><volume>91</volume>: <fpage>1261</fpage>&#x2013;<lpage>1264</lpage><pub-id pub-id-type="pmid">8108398</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Hepburn1">
        <label>56</label>
        <mixed-citation publication-type="journal"><name><surname>Hepburn</surname><given-names>PA</given-names></name>, <name><surname>Margison</surname><given-names>GP</given-names></name>, <name><surname>Tisdale</surname><given-names>MJ</given-names></name> (<year>1991</year>) <article-title>Enzymatic methylation of cytosine in DNA is prevented by adjacent O6-methylguanine residues</article-title>. <source>J Biol Chem</source><volume>266</volume>: <fpage>7985</fpage>&#x2013;<lpage>7987</lpage><pub-id pub-id-type="pmid">2022628</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Tan1">
        <label>57</label>
        <mixed-citation publication-type="journal"><name><surname>Tan</surname><given-names>NW</given-names></name>, <name><surname>Li</surname><given-names>BFL</given-names></name> (<year>1990</year>) <article-title>Interaction of oligonucleotides containing 6-O-methylguanine with human DNA (cytosine-5-)-methyltransferase</article-title>. <source>Biochemistry</source><volume>29</volume>: <fpage>9234</fpage>&#x2013;<lpage>9240</lpage><pub-id pub-id-type="pmid">2271591</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Xiao1">
        <label>58</label>
        <mixed-citation publication-type="journal"><name><surname>Xiao</surname><given-names>W</given-names></name>, <name><surname>Samson</surname><given-names>L</given-names></name> (<year>1993</year>) <article-title>In vivo evidence for endogenous DNA alkylation damage as a source of spontaneous mutation in eukaryotic cells</article-title>. <source>Proc Natl Acad Sci USA</source><volume>90</volume>: <fpage>2117</fpage>&#x2013;<lpage>2121</lpage><pub-id pub-id-type="pmid">7681584</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Ehrlich1">
        <label>59</label>
        <mixed-citation publication-type="journal"><name><surname>Ehrlich</surname><given-names>M</given-names></name> (<year>2009</year>) <article-title>DNA hypomethylation in cancer cells</article-title>. <source>Epigenomics</source><volume>1</volume>: <fpage>239</fpage>&#x2013;<lpage>259</lpage><pub-id pub-id-type="pmid">20495664</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Ehrlich2">
        <label>60</label>
        <mixed-citation publication-type="journal"><name><surname>Ehrlich</surname><given-names>M</given-names></name> (<year>2002</year>) <article-title>DNA methylation in cancer: too much, but also too little</article-title>. <source>Oncogene</source><volume>21</volume>: <fpage>5400</fpage>&#x2013;<lpage>5413</lpage><pub-id pub-id-type="pmid">12154403</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0096404-Subramanian1">
        <label>61</label>
        <mixed-citation publication-type="journal"><name><surname>Subramanian</surname><given-names>A</given-names></name>, <name><surname>Tamayo</surname><given-names>P</given-names></name>, <name><surname>Mootha</surname><given-names>VK</given-names></name>, <name><surname>Mukherjee</surname><given-names>S</given-names></name>, <name><surname>Ebert</surname><given-names>BL</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc Natl Acad Sci USA</source><volume>102</volume>: <fpage>15545</fpage>&#x2013;<lpage>15550</lpage><pub-id pub-id-type="pmid">16199517</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
